STOCK TITAN

Xcel Brands flags doubt over meeting obligations

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Xcel Brands, Inc. (XELB) reported third-quarter net licensing revenue of $1.060 million, compared with $1.118 million a year earlier; the decline primarily reflected the sale of the Judith Ripka brand, partly offset by growth in other brands. Net loss attributable to Xcel stockholders was $2.348 million, versus $7.899 million; the prior-year quarter included a $5.494 million loss from equity investments.

Xcel sold substantially all Judith Ripka assets in April 2026 for $2.30 million cash at closing, plus contingent earn-out consideration, and recognized a $0.64 million earn-out receivable. For the nine months ended September 30, 2026, operating activities used $2.883 million; cash, cash equivalents and restricted cash totaled $751,000 at period end, including $134,000 in cash and cash equivalents. Debt’s net carrying amount was $12.687 million at September 30, 2026.

Management stated that substantial doubt remains about Xcel’s ability to meet obligations due within 12 months from issuance of the financial statements. Nasdaq notified Xcel that its share price had been below $1.00 for 30 consecutive business days. The 180-calendar-day period to regain compliance runs through March 29, 2027; failure could result in loss of access to share issuance through the equity-line and at-the-market facilities.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate pointQuarterly net loss narrowed to $2.348 million from $7.899 million.

Negative

  • Major pointManagement cited substantial doubt about meeting obligations within 12 months.
  • Moderate point. Forward-looking: it has not happened yet and may not happen.Nasdaq’s bid-price notice gives Xcel until March 29, 2027 to regain compliance.
Net licensing revenue $1.060 million Three months ended September 30, 2026; $1.118 million in 2025
Net loss attributable to Xcel stockholders $2.348 million Three months ended September 30, 2026; $7.899 million in 2025
Cash, cash equivalents and restricted cash $751,000 At September 30, 2026
Net cash used in operating activities $2.883 million Nine months ended September 30, 2026
Debt net carrying amount $12.687 million At September 30, 2026
Equity-line commitment Up to $15.0 million Common stock purchase agreement with White Lion
At-the-market facility maximum aggregate offering price $10,000,000 Equity distribution agreement entered into August 18, 2026
Minimum bid price $1.00 per share Below the requirement for 30 consecutive business days; compliance period runs through March 29, 2027
going concern financial
"continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
working capital deficit financial
"a working capital deficit"
A working capital deficit occurs when a company's short-term obligations—like bills, supplier payments and near-term debt—are larger than its readily available short-term resources such as cash, money expected from customers, and inventory that can be sold. Like a household whose monthly bills exceed its checking account, it signals potential difficulty paying immediate expenses, which matters to investors because it raises the chance the company will need outside financing or cut operations, affecting risk and value.
at-the-market offering financial
"deemed to be an “at-the-market offering”"
An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.
paid in-kind (PIK) financial
"interest on the Term Loan B will be paid in-kind (“PIK”)"
embedded derivative financial
"represents an embedded derivative"
An embedded derivative is a built-in feature inside a contract—like a bond, loan, or lease—that causes part of the payout to change based on something else, such as a stock price, interest rate, or commodity price. It matters to investors because that hidden feature can add separate risk and volatility to a security’s value and accounting treatment, like finding a removable engine in a car that changes how fast it can go and how much it’s worth.
Adjusted EBITDA financial
"We had Adjusted EBITDA of approximately $(0.46) million"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much stock can XELB sell through its equity line and at-the-market facility?

Xcel’s equity line gives it the right, but not the obligation, to sell up to $15.0 million of common stock to White Lion, subject to a limit of 1,178,173 shares unless stockholder approval or specified average-price conditions permit more. Its separate at-the-market agreement allows sales up to a $10,000,000 maximum aggregate offering price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001083220--12-312026Q3false001http://www.xcelbrands.com/20260930#JudithRipkaBrandMemberhttp://www.xcelbrands.com/20260930#JudithRipkaBrandMemberP25Y0.0850.500001083220us-gaap:CommonStockMember2026-01-012026-03-310001083220us-gaap:CommonStockMember2025-04-012025-06-300001083220us-gaap:CommonStockMember2025-01-012025-03-310001083220xelb:HalstonBrandMembersrt:MinimumMember2023-05-152023-05-150001083220xelb:HalstonBrandMembersrt:MaximumMember2023-05-152023-05-150001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMember2025-03-312025-03-310001083220xelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberxelb:AmendedServicesAgreementMember2024-04-122024-04-120001083220xelb:IMTopcoLLCMember2025-01-012025-03-310001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-04-260001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-04-270001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-07-012026-09-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-01-012026-09-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-09-300001083220us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:TrademarksMember2026-03-310001083220us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:CopyrightsMember2026-03-310001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberus-gaap:PrepaidExpenseAndOtherAssetsCurrent2026-09-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberus-gaap:OtherAssetsNoncurrent2026-09-300001083220xelb:LiquidAssetCovenantRequirementBeforeRepaymentOfFirstOutObligationsMemberxelb:TermLoanaMember2026-03-200001083220xelb:LiquidAssetCovenantRequirementAfterFirstOutObligationsAreFullyPaidMember2026-03-200001083220xelb:LiquidAssetCovenantRequirementBeforeRepaymentOfFirstOutObligationsMemberxelb:TermLoanaMember2026-02-200001083220xelb:LiquidAssetCovenantRequirementAfterFirstOutObligationsAreFullyPaidMember2026-02-200001083220xelb:IMTopcoLLCMember2025-03-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2026-07-012026-09-300001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2025-07-012025-09-300001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2025-01-012025-09-300001083220xelb:WhiteLionCapitalLlcMember2026-01-212026-01-210001083220us-gaap:WarrantMember2025-01-012025-12-310001083220us-gaap:WarrantMember2026-01-012026-09-300001083220xelb:IMTopcoLLCMember2025-09-262025-09-260001083220xelb:HalstonBrandMember2023-05-152023-05-150001083220xelb:NewTermLoanDebtMember2025-04-212025-04-210001083220xelb:HilcoGlobalMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2026-01-012026-09-300001083220us-gaap:VariableInterestEntityPrimaryBeneficiaryMemberxelb:LongabergerLicensingLLCMember2026-01-012026-09-300001083220us-gaap:AdditionalPaidInCapitalMemberxelb:EquityLineFacilityMember2026-07-012026-09-300001083220xelb:EquityLineFacilityMember2026-07-012026-09-300001083220us-gaap:AdditionalPaidInCapitalMemberxelb:EquityLineFacilityMember2026-04-012026-06-300001083220xelb:EquityLineFacilityMember2026-04-012026-06-300001083220xelb:NonManagementDirectorsMemberus-gaap:RestrictedStockMember2026-04-202026-04-200001083220srt:DirectorMemberus-gaap:CommonStockMember2026-04-012026-06-300001083220xelb:DirectorsAndManagementMemberus-gaap:CommonStockMember2025-04-012025-06-300001083220us-gaap:CommonStockMemberxelb:EquityLineFacilityMember2026-07-012026-09-300001083220us-gaap:CommonStockMemberxelb:EquityLineFacilityMember2026-04-012026-06-300001083220us-gaap:CommonStockMember2025-07-012025-09-300001083220xelb:ConsultantMemberus-gaap:RestrictedStockMember2026-07-232026-07-230001083220xelb:ConsultantMemberus-gaap:RestrictedStockMember2026-04-242026-04-240001083220us-gaap:CommonStockMember2026-04-012026-06-300001083220us-gaap:CommonStockMember2026-07-012026-09-300001083220us-gaap:RetainedEarningsMember2026-09-300001083220us-gaap:NoncontrollingInterestMember2026-09-300001083220us-gaap:AdditionalPaidInCapitalMember2026-09-300001083220us-gaap:RetainedEarningsMember2026-06-300001083220us-gaap:NoncontrollingInterestMember2026-06-300001083220us-gaap:AdditionalPaidInCapitalMember2026-06-3000010832202026-06-300001083220us-gaap:RetainedEarningsMember2026-03-310001083220us-gaap:NoncontrollingInterestMember2026-03-310001083220us-gaap:AdditionalPaidInCapitalMember2026-03-3100010832202026-03-310001083220us-gaap:RetainedEarningsMember2025-12-310001083220us-gaap:NoncontrollingInterestMember2025-12-310001083220us-gaap:AdditionalPaidInCapitalMember2025-12-310001083220us-gaap:RetainedEarningsMember2025-09-300001083220us-gaap:NoncontrollingInterestMember2025-09-300001083220us-gaap:AdditionalPaidInCapitalMember2025-09-300001083220us-gaap:RetainedEarningsMember2025-06-300001083220us-gaap:NoncontrollingInterestMember2025-06-300001083220us-gaap:AdditionalPaidInCapitalMember2025-06-3000010832202025-06-300001083220us-gaap:RetainedEarningsMember2025-03-310001083220us-gaap:NoncontrollingInterestMember2025-03-310001083220us-gaap:AdditionalPaidInCapitalMember2025-03-3100010832202025-03-310001083220us-gaap:RetainedEarningsMember2024-12-310001083220us-gaap:NoncontrollingInterestMember2024-12-310001083220us-gaap:AdditionalPaidInCapitalMember2024-12-310001083220us-gaap:CommonStockMember2026-09-300001083220us-gaap:CommonStockMember2026-06-300001083220us-gaap:CommonStockMember2026-03-310001083220us-gaap:CommonStockMember2025-12-310001083220us-gaap:CommonStockMember2025-09-300001083220us-gaap:CommonStockMember2025-06-300001083220us-gaap:CommonStockMember2025-03-310001083220us-gaap:CommonStockMember2024-12-3100010832202025-01-012025-12-310001083220us-gaap:EmployeeStockOptionMemberxelb:ShareBasedPaymentArrangementTrancheFourMember2026-09-300001083220us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-09-300001083220us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2026-09-300001083220us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-09-300001083220us-gaap:EmployeeStockOptionMember2026-09-300001083220us-gaap:EmployeeStockOptionMember2025-12-310001083220xelb:NonManagementDirectorsMemberus-gaap:EmployeeStockOptionMember2026-04-202026-04-200001083220xelb:EquityIncentivePlan2011Member2026-09-300001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2026-01-012026-09-300001083220us-gaap:RestrictedStockMember2025-12-310001083220srt:ExecutiveOfficerMemberus-gaap:CommonStockMember2026-07-012026-09-300001083220srt:ExecutiveOfficerMemberus-gaap:CommonStockMember2026-01-012026-09-300001083220xelb:NonManagementDirectorsMemberus-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-04-202026-04-200001083220xelb:NonManagementDirectorsMemberus-gaap:RestrictedStockMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-04-202026-04-200001083220xelb:NonManagementDirectorsMemberus-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2026-04-202026-04-200001083220xelb:NonManagementDirectorsMemberus-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2026-04-202026-04-200001083220xelb:EquityLineFacilityMember2026-01-012026-09-300001083220xelb:YearEndingDecember312025Memberxelb:AmendedServicesAgreementMember2024-04-120001083220xelb:TwelveMonthPeriodEndingMarch312025Memberxelb:AmendedServicesAgreementMember2024-04-120001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001083220xelb:HalstonBrandMember2026-07-012026-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001083220xelb:HalstonBrandMember2026-01-012026-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300001083220xelb:HalstonBrandMember2025-07-012025-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-300001083220xelb:HalstonBrandMember2025-01-012025-09-300001083220us-gaap:LetterOfCreditMember2026-09-300001083220xelb:NewTermLoanDebtMember2025-12-310001083220us-gaap:LetterOfCreditMember2025-12-310001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-07-012026-09-300001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-01-012026-09-300001083220us-gaap:RetainedEarningsMember2026-07-012026-09-300001083220us-gaap:RetainedEarningsMember2026-04-012026-06-300001083220us-gaap:RetainedEarningsMember2026-01-012026-03-310001083220us-gaap:RetainedEarningsMember2025-07-012025-09-300001083220us-gaap:NoncontrollingInterestMember2025-07-012025-09-300001083220us-gaap:RetainedEarningsMember2025-04-012025-06-300001083220us-gaap:NoncontrollingInterestMember2025-04-012025-06-300001083220us-gaap:RetainedEarningsMember2025-01-012025-03-310001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-04-132026-04-130001083220xelb:FirstEagleAlternativeCreditLlcMember2026-04-012026-04-300001083220xelb:FirstEagleAlternativeCreditLlcMember2024-12-122024-12-120001083220xelb:WhiteLionCapitalLlcMemberxelb:EquityLineFacilityMember2026-07-012026-09-300001083220xelb:WhiteLionCapitalLlcMemberxelb:EquityLineFacilityMember2026-01-012026-09-300001083220xelb:AtMarketFacilityMember2026-08-182026-08-180001083220us-gaap:SellingGeneralAndAdministrativeExpense2026-07-012026-09-300001083220us-gaap:SellingGeneralAndAdministrativeExpense2026-01-012026-09-300001083220us-gaap:SellingGeneralAndAdministrativeExpense2025-07-012025-09-300001083220us-gaap:SellingGeneralAndAdministrativeExpense2025-01-012025-09-300001083220xelb:NewTermLoanDebtMember2026-07-012026-09-300001083220xelb:NewTermLoanDebtMember2026-01-012026-09-300001083220xelb:NewTermLoanDebtMember2025-07-012025-09-300001083220xelb:NewTermLoanDebtMember2025-01-012025-09-300001083220us-gaap:SeniorNotesMember2026-07-012026-09-300001083220us-gaap:SeniorNotesMember2026-01-012026-09-300001083220us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2026-01-012026-09-300001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:TermLoanaMember2026-04-132026-04-130001083220xelb:IpxCapitalLlcMemberxelb:TermLoanaMember2026-01-012026-09-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberus-gaap:LicenseMember2026-04-240001083220us-gaap:TrademarksMember2026-09-300001083220us-gaap:IntellectualPropertyMember2026-09-300001083220us-gaap:TrademarksMember2025-12-310001083220us-gaap:IntellectualPropertyMember2025-12-310001083220xelb:XcelBrandsMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberxelb:AmendedServicesAgreementMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:IfRoyaltiesReceivableLessThanSpecifiedAmountMemberxelb:AmendedServicesAgreementMember2024-04-120001083220xelb:XcelBrandsMemberxelb:IMTopcoLLCMemberxelb:AmendedServicesAgreementMember2024-04-120001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMemberxelb:AmendedServicesAgreementMember2024-04-120001083220xelb:IMTopcoLLCMember2025-07-012025-09-300001083220xelb:IMTopcoLLCMember2025-01-012025-09-300001083220us-gaap:RestrictedStockMember2026-09-300001083220us-gaap:EmployeeStockOptionMember2026-09-300001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-04-242026-04-240001083220us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMemberus-gaap:TrademarksMember2026-01-012026-03-310001083220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-04-240001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:TermLoanbMember2025-04-210001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:TermLoanaMember2025-04-210001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:TermLoanbMember2024-12-120001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:TermLoanaMember2024-12-120001083220xelb:FirstEagleAlternativeCreditLlcMemberus-gaap:DelayedDrawTermLoanMember2024-12-120001083220xelb:HalstonBrandMember2026-09-300001083220xelb:HalstonBrandMember2025-12-310001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-04-300001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:NewTermLoanDebtMember2025-04-210001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:NewTermLoanDebtMember2024-12-120001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-10-132026-10-130001083220xelb:FirstEagleAlternativeCreditLlcMember2025-04-210001083220xelb:FirstEagleAlternativeCreditLlcMember2024-12-120001083220xelb:RestoreCapitalLlcMemberxelb:TermLoanbMember2026-09-300001083220xelb:FirstEagleAlternativeCreditLlcMemberxelb:TermLoanaMember2026-09-300001083220xelb:IpxCapitalLlcMemberxelb:TermLoanaMember2026-04-300001083220xelb:IpxCapitalLlcMemberxelb:TermLoanaMember2025-12-310001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-05-172026-05-170001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-05-170001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-04-130001083220xelb:TermLoanaMember2026-03-200001083220xelb:TermLoanaMember2026-02-200001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-09-300001083220xelb:TermLoanbMember2026-09-300001083220xelb:TermLoanaMember2026-09-300001083220xelb:NewTermLoanDebtMember2026-09-300001083220xelb:TermLoanaMember2026-04-130001083220xelb:NewTermLoanDebtMember2025-12-310001083220xelb:NewLoanAndSecurityAgreementMember2025-04-210001083220xelb:NewLoanAndSecurityAgreementMember2024-12-120001083220xelb:HalstonBrandMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-07-012026-09-300001083220xelb:HalstonBrandMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-01-012026-09-300001083220xelb:HalstonBrandMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-07-012025-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-12-310001083220xelb:HalstonBrandMemberus-gaap:LicenseMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2025-01-012025-09-300001083220us-gaap:RestrictedStockUnitsRSUMember2026-09-300001083220xelb:IpxCapitalLlcMemberus-gaap:SeniorNotesMember2026-04-130001083220us-gaap:RestrictedStockUnitsRSUMember2025-12-310001083220xelb:HalstonBrandMemberxelb:UnexercisedStockOptionsMemberxelb:UnexercisedWarrantsRelatedToHalstonMasterLicenseMemberxelb:NotRelatedToPlanMember2026-09-300001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2021Member2026-09-300001083220xelb:UnexercisedStockOptionsMemberxelb:EquityIncentivePlan2011Member2026-09-300001083220xelb:UnexercisedWarrantsIssuedThroughVariousCorporateTransactionsMember2026-09-300001083220xelb:EquityIncentivePlan2021Member2026-09-300001083220us-gaap:SeniorNotesMember2026-09-300001083220us-gaap:WarrantMember2026-09-300001083220us-gaap:WarrantMember2025-12-310001083220xelb:HalstonBrandMemberus-gaap:WarrantMember2023-05-1500010832202024-12-3100010832202025-09-300001083220xelb:ImWhpLlcMemberxelb:IMTopcoLLCMember2024-12-310001083220us-gaap:WarrantMember2026-07-012026-09-300001083220us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001083220us-gaap:WarrantMember2026-01-012026-09-300001083220us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001083220us-gaap:WarrantMember2025-07-012025-09-300001083220us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001083220us-gaap:WarrantMember2025-01-012025-09-300001083220us-gaap:EmployeeStockOptionMember2025-01-012025-09-300001083220xelb:PurchasersMemberus-gaap:SeniorNotesMember2026-04-012026-04-300001083220xelb:FirstEagleAlternativeCreditLlcMember2026-01-012026-09-300001083220xelb:FirstEagleAlternativeCreditLlcMember2025-04-212025-04-210001083220xelb:EmployeeMember2026-07-012026-09-300001083220xelb:DirectorAndConsultantsMember2026-07-012026-09-300001083220us-gaap:RestrictedStockMember2026-07-012026-09-300001083220us-gaap:EmployeeStockOptionMember2026-07-012026-09-300001083220xelb:ChiefExecutiveOfficerAndExecutiveVicePresidentMember2026-01-212026-01-210001083220xelb:EmployeeMember2026-01-012026-09-300001083220xelb:DirectorAndConsultantsMember2026-01-012026-09-300001083220us-gaap:RestrictedStockMember2026-01-012026-09-300001083220us-gaap:EmployeeStockOptionMember2026-01-012026-09-300001083220xelb:EmployeeMember2025-07-012025-09-300001083220xelb:DirectorAndConsultantsMember2025-07-012025-09-300001083220us-gaap:RestrictedStockMember2025-07-012025-09-300001083220us-gaap:EmployeeStockOptionMember2025-07-012025-09-300001083220xelb:EmployeeMember2025-01-012025-09-300001083220xelb:DirectorAndConsultantsMember2025-01-012025-09-300001083220us-gaap:RestrictedStockMember2025-01-012025-09-300001083220us-gaap:EmployeeStockOptionMember2025-01-012025-09-3000010832202025-01-012025-09-300001083220xelb:WhiteLionCapitalLlcMember2026-01-012026-09-300001083220us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-300001083220us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-3000010832202026-04-012026-06-300001083220us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-3100010832202026-01-012026-03-310001083220us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-3000010832202025-07-012025-09-300001083220us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-3000010832202025-04-012025-06-300001083220us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-3100010832202025-01-012025-03-310001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2026-09-300001083220xelb:RoyaltyAgreementWithQurateRetailGroupMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2025-12-3100010832202026-09-3000010832202025-12-3100010832202026-07-012026-09-3000010832202026-11-1200010832202026-01-012026-09-30xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purexelb:segment

Table of Contents

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

​

FORM 10-Q

​

☒    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

​

For the quarterly period ended September 30, 2026

or

​

☐    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

​

For the transition period from ___ to ___

​

Commission File Number: 001-37527

​

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

​

Delaware

  ​ ​ ​

76-0307819

(State or Other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

​

​

 

550 Seventh Avenue, 11th Floor, New York, NY 10018

 

 

(Address of Principal Executive Offices)

 

​

(347) 727-2474

(Issuer’s Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

  ​ ​ ​

Trading Symbol

  ​ ​ ​

Name of each exchange on which registered

Common Stock, $0.001 par value per share

​

XELB

​

NASDAQ Capital Market

​

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   ☒      No   ☐

​

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   ☒    No   ☐

​

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

​

​

​

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company   ☒

 

Emerging growth company   ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

​

Indicate by a check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   ☐    No   ☒

​

As of November 12, 2026, there were 7,614,217 shares of common stock, $.001 par value per share, of the issuer outstanding.

​

​

​

​

Table of Contents

XCEL BRANDS, INC.

INDEX

​

a

​

​

Page

​

​

​

PART I - FINANCIAL INFORMATION

3

​

​

​

Item 1.

Financial Statements

3

​

​

​

​

Unaudited Condensed Consolidated Balance Sheets

3

​

​

​

​

Unaudited Condensed Consolidated Statements of Operations

4

​

​

​

​

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

5

​

​

​

​

Unaudited Condensed Consolidated Statements of Cash Flows

7

​

​

​

​

Notes to Unaudited Condensed Consolidated Financial Statements

8

​

​

​

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

27

​

​

​

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

38

​

​

​

Item 4.

Controls and Procedures

38

​

​

​

PART II - OTHER INFORMATION

39

​

​

​

Item 1.

Legal Proceedings

39

​

​

​

Item 1A.

Risk Factors

39

​

​

​

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

40

​

​

​

Item 3.

Defaults Upon Senior Securities

40

​

​

​

Item 4.

Mine Safety Disclosures

40

​

​

​

Item 5.

Other Information

41

​

​

​

Item 6.

Exhibits

41

​

​

​

​

Signatures

41

​

​

2

Table of Contents

PART I. FINANCIAL INFORMATION

​

ITEM 1.    FINANCIAL STATEMENTS

​

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

​

​

​

​

​

​

​

​

​

  ​ ​ ​

September 30, 2026

  ​ ​ ​

December 31, 2025

​

​

(Unaudited)

​

(Note 1)

Assets

 

​

  ​

 

​

  ​

Current Assets:

 

​

  ​

 

​

  ​

Cash and cash equivalents

​

$

134

​

$

1,150

Accounts receivable, net

​

 

535

​

 

956

Prepaid expenses and other current assets

​

 

364

​

 

1,564

Total current assets

​

 

1,033

​

 

3,670

Non-current Assets:

​

​

​

​

​

​

Property and equipment, net

​

 

92

​

 

130

Operating lease right-of-use assets

​

​

2,406

​

​

3,005

Trademarks and other intangibles, net

​

 

26,144

​

 

31,229

Other assets

​

 

1,287

​

 

912

Total non-current assets

​

 

29,929

​

 

35,276

​

​

​

​

​

​

​

Total Assets

​

$

30,962

​

$

38,946

​

​

​

​

​

​

​

Liabilities and Stockholders' Equity

​

 

  ​

​

 

  ​

Current Liabilities:

​

 

  ​

​

 

  ​

Accounts payable

​

$

727

​

$

621

Accrued expenses and other current liabilities

​

​

562

​

​

600

Deferred revenue

​

 

1,420

​

 

1,330

Current portion of operating lease obligations

​

​

1,802

​

​

1,687

Current portion of long-term debt

​

 

2,117

​

 

3,250

Total current liabilities

​

 

6,628

​

 

7,488

Long-Term Liabilities:

​

 

  ​

​

 

  ​

Deferred revenue

​

​

1,111

​

​

1,778

Long-term portion of operating lease obligations

​

​

2,309

​

​

3,678

Long-term debt, net, less current portion

​

 

10,570

​

 

9,456

Other long-term liabilities

​

 

901

​

 

722

Total long-term liabilities

​

 

14,891

​

 

15,634

Total Liabilities

​

 

21,519

​

 

23,122

​

​

​

​

​

​

​

Commitments and Contingencies

​

 

  ​

​

 

  ​

​

​

​

​

​

​

​

Stockholders' Equity:

​

 

  ​

​

 

  ​

Preferred stock, $.001 par value, 1,000,000 shares authorized, none issued and outstanding

​

 

—

​

 

—

Common stock, $.001 par value, 50,000,000 shares authorized, and 6,991,228 and 5,880,757 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively

​

 

7

​

 

6

Paid-in capital

​

 

112,591

​

 

111,660

Accumulated deficit

​

 

(101,018)

​

 

(93,705)

Total Xcel Brands, Inc. stockholders' equity

​

 

11,580

​

 

17,961

Noncontrolling interest

​

​

(2,137)

​

​

(2,137)

Total Stockholders' Equity

​

 

9,443

​

 

15,824

​

​

​

​

​

​

​

Total Liabilities and Stockholders' Equity

​

$

30,962

​

$

38,946

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

3

Table of Contents

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the Three Months Ended

​

For the Nine Months Ended

​

​

​

September 30, 

​

September 30, 

​

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

​

Revenues

 

​

  ​

 

​

  ​

​

​

  ​

 

​

  ​

​

Net licensing revenue

​

$

1,060

​

$

1,118

​

$

3,325

​

$

3,771

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Direct operating costs and expenses

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

Salaries, benefits and employment taxes

​

 

830

​

 

956

​

 

2,544

​

 

3,026

​

Other selling, general and administrative expenses

​

 

971

​

 

1,214

​

 

3,189

​

 

3,323

​

Total direct operating costs and expenses

​

 

1,801

​

 

2,170

​

 

5,733

​

 

6,349

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Operating loss before other operating costs and expenses

​

​

(741)

​

​

(1,052)

​

​

(2,408)

​

​

(2,578)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Other operating costs and expenses

​

​

​

​

​

​

​

​

​

​

​

​

​

Depreciation and amortization

​

 

812

​

 

896

​

 

2,518

​

 

2,695

​

Charges related to the sale of the Judith Ripka brand

​

​

—

​

​

—

​

​

96

​

​

—

​

Loss from equity investments

​

​

—

​

​

5,494

​

​

—

​

​

6,010

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Operating loss

​

 

(1,553)

​

 

(7,442)

​

 

(5,022)

​

 

(11,283)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Interest and finance expense (income)

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

Interest expense

​

 

733

​

 

470

​

 

1,935

​

 

1,400

​

Other finance charges (income), net

​

 

49

​

 

52

​

 

161

​

 

169

​

Loss on early extinguishment of debt

​

​

—

​

​

—

​

​

151

​

​

1,850

​

Interest and finance expense (income), net

​

 

782

​

 

522

​

 

2,247

​

 

3,419

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Loss before income taxes

​

 

(2,335)

​

 

(7,964)

​

 

(7,269)

​

 

(14,702)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Income tax provision (benefit)

​

 

13

​

 

25

​

 

44

​

 

75

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

​

​

(2,348)

​

​

(7,989)

​

​

(7,313)

​

​

(14,777)

​

(Income) loss attributable to noncontrolling interest

​

​

—

​

​

90

​

​

—

​

​

93

​

Net loss attributable to Xcel Brands, Inc. stockholders

​

$

(2,348)

​

$

(7,899)

​

$

(7,313)

​

$

(14,684)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Loss per common share attributable to Xcel Brands, Inc. stockholders:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

Basic and diluted net loss per share

​

$

(0.35)

​

$

(2.02)

​

$

(1.17)

​

$

(5.06)

​

Weighted average number of common shares outstanding:

​

 

  ​

​

 

  ​

​

 

  ​

​

 

  ​

​

Basic and diluted weighted average common shares outstanding

​

 

6,696,860

​

 

3,918,993

​

 

6,256,136

​

 

2,904,399

​

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

4

Table of Contents

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Xcel Brands, Inc. Stockholders

​

​

​

​

​

​

​

​

Common Stock

​

​

​

​

​

​

​

​

​

​

​

​

Number of

​

​

​

​

Paid-In

​

Accumulated

​

Noncontrolling

​

​

​

  ​ ​ ​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Interest

​

Total

Balance as of December 31, 2024

 

2,368,072

​

$

2

​

$

106,666

​

$

(76,244)

​

$

(2,026)

​

$

28,398

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Additional impact related to fractional shares from reverse stock split

​

(57)

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

33

​

​

—

​

​

—

​

​

33

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants held by licensee

 

—

​

 

—

​

 

10

​

 

—

​

 

—

​

 

10

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to executives for pro rata portion of base salaries, net of withholding taxes

​

18,310

​

​

—

​

​

66

​

​

—

​

​

—

​

​

66

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

 

—

​

 

—

​

 

—

​

 

(2,797)

​

​

—

​

 

(2,797)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of March 31, 2025

 

2,386,325

​

​

2

​

​

106,775

​

​

(79,041)

​

​

(2,026)

​

​

25,710

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

54

​

​

—

​

​

—

​

​

54

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants held by licensee

​

—

​

​

—

​

​

9

​

​

—

​

 

—

​

​

9

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Warrants issued and amended in connection with refinancing of term loan debt

​

—

​

​

—

​

​

648

​

​

—

​

​

—

​

​

648

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to management and directors in connection with restricted stock grants

​

21,500

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to executives for pro rata portion of base salaries, net of withholding taxes

​

29,675

​

​

—

​

​

66

​

​

—

​

​

—

​

​

66

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

 

—

​

​

—

​

​

—

​

​

(3,988)

​

​

(3)

​

​

(3,991)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of June 30, 2025

 

2,437,500

​

​

2

​

​

107,552

​

​

(83,029)

​

​

(2,029)

​

​

22,496

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

40

​

​

—

​

​

—

​

​

40

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants held by licensee

​

—

​

​

—

​

​

9

​

​

—

​

​

—

​

​

9

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to executives for pro rata portion of base salaries, net of withholding taxes

​

44,416

​

​

—

​

​

59

​

​

—

​

​

—

​

​

59

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued in connection with public offering and private placement transactions, net of transaction costs

​

2,324,860

​

​

3

​

​

1,962

​

​

—

​

​

—

​

​

1,965

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

​

—

​

​

—

​

​

—

​

​

(7,899)

​

​

(90)

​

​

(7,989)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of September 30, 2025

​

4,806,776

​

$

5

​

$

109,622

​

$

(90,928)

​

$

(2,119)

​

$

16,580

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of December 31, 2025

 

5,880,757

​

$

6

​

$

111,660

​

$

(93,705)

​

$

(2,137)

​

$

15,824

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

51

​

​

—

​

​

—

​

​

51

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants held by licensee

​

—

​

​

—

​

​

10

​

​

—

​

​

—

​

​

10

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to executive for pro rata portion of base salary, net of withholding taxes

​

32,735

​

​

—

​

​

43

​

​

—

​

​

—

​

​

43

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Costs incurred related to equity line facility

​

—

​

​

—

​

​

(258)

​

​

—

​

​

—

​

​

(258)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

 

—

​

 

—

​

 

—

​

 

(2,489)

​

​

—

​

 

(2,489)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of March 31, 2026

 

5,913,492

​

​

6

​

​

111,506

​

​

(96,194)

​

​

(2,137)

​

​

13,181

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

15

​

​

—

​

​

—

​

​

15

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants held by licensee

 

—

​

 

—

​

 

9

​

 

—

​

 

—

​

 

9

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued in connection with issuance of Senior Secured Notes

​

100,579

​

​

—

​

​

121

​

​

—

​

​

—

​

​

121

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued as consideration for entry into equity line facility

​

16,094

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued under equity line facility, net

​

348,000

​

​

—

​

​

673

​

​

—

​

​

—

​

​

673

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to service provider under marketing agreement

​

62,112

​

​

—

​

​

137

​

​

—

​

​

—

​

​

137

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to directors in connection with restricted stock grants

​

5,000

​

​

—

​

​

—

​

​

—

​

​

—

​

​

—

​

5

Table of Contents

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Xcel Brands, Inc. Stockholders

​

​

​

​

​

​

​

​

Common Stock

​

​

​

​

​

​

​

​

​

​

​

​

Number of

​

​

​

​

Paid-In

​

Accumulated

​

Noncontrolling

​

​

​

​

Shares

  ​ ​ ​

Amount

  ​ ​ ​

Capital

  ​ ​ ​

Deficit

  ​ ​ ​

Interest

​

Total

Shares issued to executive for pro rata portion of base salary, net of withholding taxes

​

29,905

​

​

—

​

​

62

​

​

—

​

​

—

​

​

62

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

 

—

​

 

—

​

 

—

​

 

(2,476)

​

​

—

​

​

(2,476)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of June 30, 2026

 

6,475,182

​

​

6

​

​

112,523

​

​

(98,670)

​

​

(2,137)

​

​

11,722

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Compensation expense related to stock options and restricted stock

​

—

​

​

—

​

​

16

​

​

—

​

​

—

​

​

16

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Contra-revenue related to warrants granted to licensee

​

—

​

​

—

​

​

10

​

​

—

​

​

—

​

​

10

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued from exercise of pre-funded warrants

​

380,000

​

​

1

​

​

(1)

​

​

—

​

​

—

​

​

—

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued under equity line facility and at-the-market facility, net of related costs

​

45,558

​

​

—

​

​

(55)

​

​

—

​

​

—

​

​

(55)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to service provider under marketing agreement

​

37,313

​

​

—

​

​

50

​

​

—

​

​

—

​

​

50

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Shares issued to executives for pro rata portion of base salaries, net of withholding taxes

​

53,175

​

​

—

​

​

48

​

​

—

​

​

—

​

​

48

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net loss

​

—

​

​

—

​

​

—

​

​

(2,348)

​

​

—

​

​

(2,348)

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Balance as of September 30, 2026

​

6,991,228

​

$

7

​

$

112,591

​

$

(101,018)

​

$

(2,137)

​

$

9,443

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

6

Table of Contents

Xcel Brands, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

​

​

​

​

​

​

​

​

​

​

For the Nine Months Ended September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Cash flows from operating activities

 

​

  ​

 

​

  ​

Net loss

​

$

(7,313)

​

$

(14,777)

Adjustments to reconcile net loss to net cash used in operating activities:

​

 

​

​

 

  ​

Depreciation and amortization expense

​

 

2,518

​

 

2,695

Asset impairment and other charges related to sale of Judith Ripka brand

​

 

96

​

 

—

Paid in-kind interest expense

​

​

787

​

​

452

Amortization of deferred finance costs and other non-cash interest expense

​

 

856

​

 

238

Stock-based compensation and cost of licensee warrants

​

 

451

​

 

346

Provision for credit losses

​

​

—

​

​

30

Loss from equity investments

​

​

—

​

​

6,010

Loss on early extinguishment of debt

​

​

—

​

​

1,850

Changes in operating assets and liabilities:

​

 

​

​

 

​

Accounts receivable

​

 

421

​

 

836

Prepaid expenses and other current and non-current assets

​

 

310

​

 

319

Deferred revenue

​

​

(577)

​

​

(685)

Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities

​

 

223

​

 

(2,046)

Lease-related assets and liabilities

​

​

(655)

​

​

(489)

Other long-term liabilities

​

 

—

​

 

25

Net cash used in operating activities

​

 

(2,883)

​

 

(5,196)

​

​

​

​

​

​

​

Cash flows from investing activities

​

 

  ​

​

 

  ​

Cash consideration received from sale of Judith Ripka brand assets, net of transaction fees

​

​

2,000

​

​

—

Purchase of property and equipment

​

 

—

​

 

(10)

Net cash provided by (used in) investing activities

​

 

2,000

​

 

(10)

​

​

​

​

​

​

​

Cash flows from financing activities

​

 

  ​

​

 

  ​

Proceeds from public offering and private placement transactions, net of transaction costs

​

​

—

​

​

1,965

Proceeds from issuance of shares through equity line facility and at-the-market facility, net of transaction costs

​

​

360

​

​

—

Proceeds from long-term debt

​

​

3,006

​

​

5,670

Payment of deferred finance costs

​

 

(350)

​

 

(567)

Shares repurchased including vested restricted stock in exchange for withholding taxes

​

​

(143)

​

 

(122)

Payment of long-term debt

​

 

(4,128)

​

 

(500)

Net cash (used in) provided by financing activities

​

 

(1,255)

​

 

6,446

​

​

​

​

​

​

​

Net (decrease) increase in cash, cash equivalents, and restricted cash

​

 

(2,138)

​

 

1,240

​

​

​

​

​

​

​

Cash, cash equivalents, and restricted cash at beginning of period

​

​

2,889

​

​

1,993

​

​

​

​

​

​

​

Cash, cash equivalents, and restricted cash at end of period

​

$

751

​

$

3,233

​

​

​

​

​

​

​

Reconciliation to amounts on condensed consolidated balance sheets:

​

 

  ​

​

 

  ​

Cash and cash equivalents

​

$

134

​

$

1,494

Restricted cash (current)

​

​

—

​

​

1,000

Restricted cash (reported in other non-current assets)

​

 

617

​

 

739

Total cash, cash equivalents, and restricted cash

​

$

751

​

$

3,233

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Supplemental disclosure of cash flow information:

​

 

  ​

​

 

  ​

Cash paid during the period for interest

​

$

290

​

$

607

Cash paid during the period for income taxes

​

$

50

​

$

515

​

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

​

​

7

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

1. Nature of Operations, Background, and Basis of Presentation

Xcel Brands, Inc. (“Xcel” and, together with its subsidiaries, the “Company”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, home goods, pet products and other consumer products, and the development of influencer led brands and the acquisition of dynamic consumer lifestyle brands. The Company primarily generates revenue through the licensing of its brands through contractual arrangements with manufacturers and retailers. The Company, through its licensees, distributes through an omni-channel and social commerce sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers, and e-commerce channels.

Brand Portfolio

Currently, the Company’s brand portfolio consists of the following:

●the Halston and C Wonder brands, which are wholly owned by Xcel;
●the Longaberger by Shannon Doherty brand, which Xcel manages through its 50% ownership interest in Longaberger Licensing, LLC; the Company consolidates Longaberger Licensing, LLC and recognizes noncontrolling interest for the remaining ownership interest held by a third party (see Note 2 for additional details);
●the TowerHill by Christie Brinkley brand, which is a co-branded collaboration between Xcel and Christie Brinkley that launched in 2024;
●the Trust.Respect.Love by Cesar Millan brand, which is a new co-branded collaboration between Xcel and Cesar Millan that launched in September 2026;
●the GemmaMade by Gemma Stafford brand, which is a new co-branded collaboration between Xcel and Gemma Stafford that launched in April 2026;
●the Off/Duty by Coco Rocha brand, which is a new co-branded collaboration between Xcel and Coco Rocha that launched in October 2026; and
●Mesa Mia by Jenny Martinez, which is a brand owned by Mexican home influencer Jenny Martinez, and for which Xcel holds the television and other distribution rights through a long-term license agreement, that launched in April 2026.

Also, through April 27, 2026, the Company’s brand portfolio included the Judith Ripka brand, which was wholly owned by Xcel; this brand was sold to a third party in April 2026 (see Note 2 for additional details).

Additionally, through October 1, 2025, the Company held a noncontrolling ownership interest in the Isaac Mizrahi brand.

Basis of Presentation

The accompanying condensed consolidated balance sheet as of December 31, 2025 (which has been derived from audited financial statements) and the unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information

8

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

and pursuant to the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated by the United States Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements were prepared following the same policies and procedures used in the preparation of the audited consolidated financial statements and reflect all adjustments (consisting of normal recurring adjustments) necessary to present fairly the results of operations, financial position, and cash flows of the Company. The results of operations for the interim periods presented herein are not necessarily indicative of the results for the entire fiscal year or for any future interim periods. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on April 15, 2026.

Going Concern

The unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred recurring losses, a history of cash flows used in operating activities, a working capital deficit, and an accumulated deficit. Although the Company has undertaken significant restructuring and cost reduction efforts, obtained additional funding through a combination of equity and debt financing transactions,  and continues to explore strategic financing alternatives and operational efficiencies to improve liquidity, management has determined that there is nonetheless substantial doubt about the Company’s ability to meet its financial obligations as they become due within twelve months from the date these financial statements are issued.

​

On September 29, 2026, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that the minimum bid price per share for its common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, the Company did not meet the minimum bid price requirement set forth in the applicable listing rules. Pursuant to the applicable listing rules, the Company will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until March 29, 2027. If the Company is unable to regain compliance within this time period, the Company could lose access to the ability to issue shares of common stock through its equity line facility and at-the-market facility (as described in Note 7).

The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

​

Restricted Cash

Restricted cash at September 30, 2026 consisted of $0.62 million of cash deposited as collateral for a standby letter of credit associated with a real estate lease (reported in other non-current assets).

Restricted cash at December 31, 2025 consisted of $0.74 million of cash deposited as collateral for a standby letter of credit associated with a real estate lease (reported in other non-current assets) and $1.00 million of cash deposited in a bank account to satisfy a liquidity covenant in the Company’s term loan debt agreement (reported in other current assets).

9

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

Segment Reporting Information

The Company has a single reportable segment, which generates revenue from the design and licensing of branded apparel and similar consumer products. The Company derives revenue in North America and manages its business activities on a consolidated basis. The accounting policies of the Company’s single reportable segment are the same as those for the Company as a whole.

The Company’s chief operating decision maker, as such term is defined under GAAP, is its Chief Executive Officer. The chief operating decision maker assesses performance for the single reportable segment and decides how to allocate resources based on net income that also is reported on the income statement as consolidated net income. The chief operating decision maker analyzes and reviews business performance based on available sales data from key licensees and quarterly sales and royalty reports provided by its licensees in addition to assessing the overall operating results on a monthly basis. The measure of segment assets is reported on the balance sheet as total consolidated assets, and, as the Company has a single reportable segment, the Company’s resources are applicable to the business as a whole. The Company does not have intra-entity sales or transfers.

​

Recently Adopted Accounting Pronouncements

​

Effective January 1, 2026, the Company adopted the provisions of Accounting Standards Update (“ASU”) No. 2025-05, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets.” This ASU allows entities to elect a practical expedient that assumes, for purposes of estimating expected credit losses on accounts receivable and/or current contract assets, that current conditions as of the balance sheet date do not change for the remaining life of the asset. The adoption of this guidance did not have any significant impact on the Company’s condensed consolidated financial statements.

​

​

​

2.    Divestitures, Investments in Unconsolidated Affiliates, and Variable Interest Entities  

​

Investment in IM Topco, LLC

From May 31, 2022 through October 1, 2025, the Company held a noncontrolling equity ownership interest in IM Topco, LLC (“IM Topco”), a former subsidiary which holds the trademarks and other intellectual property rights relating to the Isaac Mizrahi brand.

From June 1, 2022 through April 15, 2025, the Company accounted for its noncontrolling interest in the ongoing operations of IM Topco as a component of other operating costs and expenses (income) under the equity method of accounting, using the distribution provisions set forth in the governing business venture agreement. On April 15, 2025, the Company discontinued the application of the equity method of accounting, and from April 15, 2025 through October 1, 2025, the Company measured its investment in IM Topco at adjusted cost, less impairment, plus or minus observable price changes of an identical or similar investment of the same issuer.

On and effective September 26, 2025, the Company, IM Topco, and the other owners of IM Topco entered into a settlement agreement, pursuant to which the Company agreed to transfer all of its remaining equity interests in IM Topco to the other owners, in exchange for (i) the release of the Company’s liability under certain agreements with IM Topco and (ii) a capital appreciation right for the Company to receive 15% of the net consideration received by IM Topco and/or the other owners in excess of $46 million in connection with any potential future capital transaction involving IM Topco which occurs on or before September 1, 2032. All remaining IM Topco equity interests were transferred to WHP on October 1, 2025.

10

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

For the three months ended September 30, 2025, the Company recognized a $5.49 million loss related to its investment in IM Topco, comprised of (i) a $5.53 million impairment charge, and (ii) a $(0.04) million adjustment related to the settlement of certain net receivables and payables between Xcel and IM Topco.

For the nine months ended September 30, 2025, the Company recognized a $6.01 million loss related to its investment in IM Topco, comprised of (i) a $5.53 million impairment charge, (ii) a $0.21 million equity method loss, (iii) a $(0.24) million adjustment to the carrying value of a contingent contractual obligation related to IM Topco, and (iv) other related costs and adjustments totaling $0.51 million.

Sale of Judith Ripka Brand

On April 24, 2026, the Company and certain of its wholly owned subsidiaries entered into an asset purchase agreement with a third-party buyer (“the Buyer”), pursuant to which the Company sold to the Buyer substantially all of the assets of the Judith Ripka brand, including the “Judith Ripka” brand name and trademarks, and assigned all licenses associated with the trademarks to the Buyer. As consideration for the sale, the asset purchase agreement provided for a $2.30 million cash payment to the Company at closing, plus additional earn-out contingent consideration. The earn-out contingent consideration is payable to the Company if certain specified license agreements related to the Judith Ripka brand are renewed following the expiration of their current term (which expire October 31, 2027) for a period of five years; in such event, the Buyer shall be obligated to make quarterly payments to the Company over a three-year period in the amount of 50% of the revenue earned by the Buyer from such licenses, subject to such payments not being less than $250,000 per year.

​

This transaction closed on April 27, 2026. Costs associated with the transaction were $0.44 million, of which $0.04 million was paid prior to closing, $0.30 million was paid at closing, and $0.10 million will be paid in future periods.

​

For the nine months ended September 30, 2026, the Company recognized net charges related to the sale of the Judith Ripka brand (consisting of impairment charges to write-down the carrying value of the Judith Ripka trademarks prior to their sale, and costs of the sale) of $0.04 million and $0.10 million, respectively.

​

Upon the sale of the Judith Ripka brand, the Company recognized $0.64 million of earn-out consideration receivable from the Buyer, based on the Company’s estimate of probable future payments to be received under the terms of the asset purchase agreement; as of September 30, 2026, $0.14 million of this amount was recorded within prepaid expenses and other current assets in the condensed consolidated balance sheet, and $0.50 million was recorded within other assets (non-current) in the condensed consolidated balance sheet. The Company also recognized a liability of $0.10 million related to remaining commission payments due, which is included within accrued expenses and other current liabilities in the condensed consolidated balance sheet as of September 30, 2026.

​

Longaberger Licensing, LLC Variable Interest Entity

Since 2019, Xcel has been party to a limited liability company agreement with a subsidiary of Hilco Global related to Longaberger Licensing, LLC (“LL”). Hilco Global is the sole Class A Member of LL, and Xcel is the sole Class B Member of LL (each individually a “Member”). Each Member holds a 50% equity ownership interest in LL; however, based on an analysis of the contractual terms and rights contained in the LLC agreement and related agreements, the Company has previously determined that under the applicable accounting standards, LL is a variable interest entity and the Company has effective control over LL. Therefore, as the primary beneficiary, the Company has consolidated LL since 2019, and

11

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

has recognized the assets, liabilities, revenues, and expenses of LL as part of its consolidated financial statements, along with a noncontrolling interest which represents Hilco Global’s 50% ownership share in LL.

​

The amount of LL's losses attributed to Hilco Global's non-controlling interest for the three and nine months ending September 30, 2026 was $0 for each period. The amount of LL's losses attributed to Hilco Global's non-controlling interest for the three and nine months ending September 30, 2025 was approximately $90,000 and $93,000, respectively.

​

​

3.    Trademarks and Other Intangibles    

Trademarks and other intangibles, net consist of the following:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Weighted

  ​ ​ ​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

 

Average

 

September 30, 2026

​

 

Amortization

​

Gross Carrying

​

Accumulated

​

Net Carrying

($ in thousands)

​

Period

​

Amount

​

Amortization

​

Amount

Trademarks (finite-lived)

 

15 years

​

 

54,408

​

 

28,264

​

 

26,144

Copyrights and other intellectual property

 

8 years

​

 

239

​

 

239

​

 

—

Total

​

​

​

$

54,647

​

$

28,503

​

$

26,144

​

​

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

Weighted

  ​ ​ ​

​

​

  ​ ​ ​

​

​

  ​ ​ ​

​

​

​

 

Average

 

December 31, 2025

​

 

Amortization

 

Gross Carrying

​

Accumulated

​

Net Carrying

($ in thousands)

​

Period

​

Amount

​

Amortization

​

Amount

Trademarks (finite-lived)

 

15 years

​

 

58,580

​

 

27,354

​

 

31,226

Copyrights and other intellectual property

 

8 years

​

 

429

​

 

426

​

 

3

Total

 

  ​

​

$

59,009

​

$

27,780

​

$

31,229

​

Amortization expense for intangible assets was approximately $0.80 million for the three-month period ended September 30, 2026 (the "current quarter") and approximately $0.88 million for the three-month period ended September 30, 2025 (the "prior year quarter").

​

Amortization expense for intangible assets was approximately $2.48 million for the nine-month period ended September 30, 2026 (the "current nine months") and approximately $2.65 million for the nine-month period ended September 30, 2025 (the "prior year nine months").

​

As of March 31, 2026, the intangible assets related to the Judith Ripka brand – which included trademarks with a gross carrying value of approximately $4.17 million and accumulated amortization of $1.57 million, and copyrights with a gross carrying value of $0.19 million and accumulated amortization of $0.19 million – were reclassified to “assets held for sale,” and were subsequently sold in April 2026 (see Note 2 for additional details). Upon reclassification to “assets held for sale,” the assets were remeasured at the lower of (i) their carrying amount or (ii) estimated fair value less cost to sell; accordingly, the Company recognized an impairment charge during the current nine months of approximately $0.06 million.

​

​

4.    Significant Contracts and Concentrations

Halston Master License

On May 15, 2023, the Company, through its wholly owned subsidiaries, H Halston, LLC and H Heritage Licensing, LLC (collectively, the “Licensor”), entered into a master license agreement relating to the Halston brand (the “Halston Master License”) with G-III Apparel Group (“G-III”), an industry-leading wholesale apparel company, for men’s and women’s apparel, men’s and women’s fashion accessories, children’s apparel and accessories, home, airline amenity and amenity

12

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

kits, and such other product categories as mutually agreed upon. The Halston Master License provided for an upfront cash payment and royalties payable to the Company, including certain guaranteed minimum royalties, includes annual minimum net sales requirements, and has a twenty-five-year term (consisting of an initial five-year period, followed by a twenty-year period), subject to G-III’s right to terminate with at least 120 days’ notice prior to the end of each five-year period during the term. G-III has an option to purchase the Halston brand for $5.0 million at the end of the twenty-five-year term, which right may be accelerated under certain conditions associated with an uncured material breach in accordance with the terms of the Halston Master License. The Licensor granted G-III a security interest in the Halston trademarks to secure the Licensor’s obligations under the Halston Master License, including to honor the obligations under the purchase option.

As a result of the upfront cash payment and guaranteed minimum royalties under the Halston Master License, the Company has recognized $2.42 million and $3.09 million of deferred revenue contract liabilities on its condensed consolidated balance sheets as of September 30, 2026 and December 31, 2025, respectively. As of December 31, 2025, approximately $1.31 million of the contract liability balance was classified as a current liability and approximately $1.78 million was classified as a long-term liability. As of September 30, 2026, approximately $1.31 million of the contract liability balance related to this agreement was classified as a current liability and approximately $1.11 million was classified as a long-term liability; the balance of these deferred revenue contract liabilities will be recognized ratably as revenue over the next 2.25 years.

Net licensing revenue recognized from the Halston Master License was $0.64 million for both the current quarter and prior year quarter, representing approximately 60% and 57% of the Company’s total net revenue for the current quarter and prior year quarter, respectively. Net licensing revenue recognized from the Halston Master License was $1.91 million for both the current nine months and prior year nine months, representing approximately 58% and 51% of the Company’s total net revenue for the current nine months and prior year nine months, respectively.

Qurate Agreements

Under the Company’s agreements with Qurate Retail Group (“Qurate”), collectively referred to as the Qurate Agreements, Qurate is obligated to make payments to the Company on a quarterly basis, based primarily upon a percentage of net retail sales of certain specified branded merchandise. Net retail sales are defined as the aggregate amount of all revenue generated through the sale of the specified branded products by Qurate and its subsidiaries under the Qurate Agreements, net of customer returns, and excluding freight, shipping and handling charges, and sales, use, or other taxes.

Net licensing revenue from the Qurate Agreements totaled $0.21 million and $0.24 million for the current quarter and prior year quarter, respectively, representing approximately 19% and 21% of the Company’s total net revenue for the current quarter and prior year quarter, respectively.

Net licensing revenue from the Qurate Agreements totaled $0.69 million and $0.81 million for the current nine months and prior year nine months, respectively, representing approximately 21% and 22% of the Company’s total net revenue for the current nine months and prior year nine months, respectively.

As of September 30, 2026 and December 31, 2025, the Company had receivables from Qurate of $0.24 million and $0.21 million, respectively, representing approximately 44% and 22% of the Company’s total net accounts receivable, respectively.

​

5. Leases

The Company is party to operating leases for real estate, and for certain equipment and storage space with a term of 12 months or less. The Company is currently not a party to any finance leases. As of September 30, 2026, the Company’s real

13

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

estate leases have a weighted-average remaining lease term of approximately 3.81 years, and the lease liabilities are measured using a weighted-average discount rate of 8.46%.

Total lease expense (net of sublease income) included in selling, general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations was approximately $0.1 million for both the current quarter and for the prior year quarter, and $0.5 million for both the current nine months, and for the prior year nine months. Cash paid for amounts included in the measurement of operating lease liabilities was approximately $0.5 million both for the current quarter and for the prior year quarter, $1.5 million for the current nine months, and $1.4 million for the prior year nine months.

As of September 30, 2026, the maturities of future lease obligations were as follows:

​

​

​

​

​

​

​

Amount

Year

  ​ ​ ​

(in thousands)

2026 (October 1 through December 31)

​

$

516

2027

​

​

1,841

2028

​

 

570

2029

​

 

585

2030

​

 

599

Thereafter (through 2032)

​

 

820

Total lease payments

​

​

4,931

Less: Discount to present value

​

​

820

Present value of lease liabilities

​

​

4,111

Current portion of lease liabilities (October 1, 2026 through September 30, 2027)

​

​

1,802

Non-current portion of lease liabilities

​

$

2,309

​

​

​

​

​

6. Debt

The Company’s net carrying amount of debt is comprised of the following:

​

​

​

​

​

​

​

​

​

​

September 30, 

​

December 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Term loan debt (including accumulated unpaid PIK interest)

​

$

11,118

​

$

13,581

Unamortized deferred finance costs & other reductions to carrying value of term loan debt

​

 

(548)

​

 

(875)

Senior secured notes

​

​

2,534

​

​

—

Unamortized deferred finance costs & other reductions to carrying value of senior secured notes

​

​

(417)

​

​

—

Total

​

 

12,687

​

 

12,706

Current portion of debt

​

 

2,117

​

 

3,250

Long-term debt

​

$

10,570

​

$

9,456

​

Term Loan Debt

As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, the Company is party to certain term loans that have undergone numerous amendments. These term loans were originally entered into on December 12, 2024, with FEAC Agent, LLC (“FEAC”), as administrative agent and collateral agent, FEF Distributors, LLC, as lead arranger, and Restore Capital, LLC, as agent for certain lenders. The term loans are guaranteed by certain direct and indirect subsidiaries of the Company, and are secured by all of the assets of the Company and such subsidiaries. The related loan agreement contains various customary financial covenants and reporting requirements, as specified and defined therein. The Company was in compliance with all applicable covenants under the related loan

14

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

agreement, or if not in compliance with certain covenants had obtained a waiver from the lenders with respect to such covenants, as of and for all periods presented in the condensed consolidated financial statements.

On February 20, 2026 and March 20, 2026, the Company entered into the fifth and sixth amendments to the loan and security agreement with the term loan debt lenders and FEAC. Pursuant to such amendments, (i) the Company prepaid $0.50 million on Term Loan A (paid from the blocked account, as defined in the loan and security agreement) in connection with the fifth amendment and irrevocably authorized FEAC (as the administrative agent) to transfer up to $0.50 million (the “Sixth Amendment Cash Collateral”) from the blocked account to an account maintained by the Administrative Agent to be held as cash collateral securing the Obligations (as defined in the loan and security agreement); (ii) the Company irrevocably authorized the administrative agent to: (a) apply all or any portion of the Sixth Amendment Cash Collateral to repay the Term Loan A, or (b) return all or any portion of the Sixth Amendment Cash Collateral to the Company, in each case at the lenders’ sole discretion; (iii) the liquid asset covenant requirement was reduced to: (a) at all times prior to the repayment in full of the First Out Obligations (as defined in the loan and security agreement), $0.50 million minus that amount of Sixth Amendment Cash Collateral used to repay Term Loan A, and (b) at all times after the repayment in full of the First Out Obligations, $0; and (iv) the transaction closing date was extended to March 24, 2026.

On April 13, 2026, the Company entered into the seventh amendment to the loan and security agreement with the term loan debt lenders and FEAC, which provided for, among other things: the ability of the Company to consummate the issuance of certain senior secured notes (as described below); the ability for IPX Capital, LLC (“IPX”), a related party, to convert its $0.50 million Term Loan A to common shares of the Company at the price per share equal to $1.35, subject to adjustment; modifications to certain payment terms; modifications to certain financial covenants; modifications to certain financial reporting requirements; and the amendment of the FEAC’s role to include certain limitations. In connection with the seventh amendment, FEAC’s affiliated lenders entered into agreements whereby a $0.50 million portion of Term Loan A was sold and assigned to IPX, and the entirety of Term Loan B was sold and assigned to UTG Capital, Inc., a Delaware corporation (“UTG”). Additionally, the Company was relieved of its obligation to pay the remaining $0.325 million amendment fee as specified in the fourth amendment.

With respect to the April 13, 2026 changes in terms related to the $0.50 million of Term Loan A debt held by IPX, and considering that IPX was a common lender for both a portion of the Term Loan A debt and a portion of the new senior secured notes (as described below), the Company evaluated and determined that the changes related to the debt held by IPX represented an extinguishment under ASC 470-50. Accordingly, the Company recognized a $0.01 million loss on early extinguishment of debt for the nine months ended September 30, 2026, due to the write-off of unamortized deferred finance costs related to such debt. The Company also evaluated the aforementioned conversion feature that was added to the Term Loan A debt held by IPX, and determined that it is not required to be separated and accounted for as a derivative under ASC 815; the Term Loan A debt is being accounted for as a single liability under ASC 470-20.

Also on April 13, 2026, the Company repaid a total of $3.25 million of Term Loan A debt – of which, $2.25 million was repaid using the net proceeds received from the issuance of the senior secured notes (as described below) and $1.00 million was paid with the Company’s restricted cash. This resulted in the repayment of all remaining principal owed to FEAC under the term loans; in connection with this repayment, the Company paid $0.14 million of fees to FEAC, which were recorded as loss on early extinguishment of debt for the nine months ended September 30, 2026.

15

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

Principal

As of September 30, 2026, the remaining principal balance of Term Loan A was $0.50 million and was due on September 20, 2027. The maturity date of this debt was subsequently extended to October 1, 2027 (see Note 12 for details).

As of September 30, 2026, the remaining principal balance of Term Loan B was $10.62 million (which includes $9.12 million of original proceeds borrowed plus $1.50 million of accumulated paid in-kind (“PIK”) interest, as discussed below) and is due at the maturity date of December 12, 2028.

Interest

From December 12, 2024 through April 20, 2025, interest on Term Loans accrued at an annual rate equal to the secured overnight financing rate as administered by the Federal Reserve Bank of New York for an interest period equal to three months (the “3-month SOFR rate”), subject to a 2.0% floor, plus (i) 8.5% for Term Loan A and Delayed Draw Term Loan and (ii) 13.5% for Term Loan B. From and after April 21, 2025, interest on the Term Loans accrues at an annual rate equal to the 3-month SOFR rate, subject to a 2.0% floor, plus (i) 8.5% for Term Loan A and (ii) 6.5% for Term Loan B.

Interest on amounts outstanding under the Term Loans accrues daily and is payable at the end of each calendar month, except that from April 21, 2025 through September 30, 2027, interest on the Term Loan B will be paid in-kind (“PIK”) by being capitalized and added to the principal amount of the Term Loan B at the end of each calendar month. For the current quarter and current nine months, the Company recognized PIK interest approximately $0.29 million and $0.80 million, respectively. For the prior year quarter and prior year nine months, the Company recognized approximately $0.26 million and $0.45 million, respectively, of PIK interest.

For the current quarter and current nine months, the Company incurred interest expense (including interest paid in cash, PIK, and the amortization of deferred finance costs) related to term loan debt of approximately $0.36 million and $1.27 million, respectively.

For the prior year quarter and prior year nine months, the Company incurred total interest expense (including interest paid in cash, PIK, and the amortization of deferred finance costs) related to term loan debt of approximately $0.39 million and $1.32 million, respectively.

Exit Fees

The amended loan agreement also requires that the Company pay an exit fee of $0.175 million to FEAC related to Term Loan A and an exit fee of $0.40 million to Restore Capital, LLC related to Term Loan B upon the maturity or full payment of the term loans. The Company recognized the cost of the Term Loan A exit fee over the remaining term of the related debt, while the net present value of the Term Loan B exit fee on April 21, 2025 was recognized as part of the loss on early extinguishment of debt recorded in the second quarter of 2025. As of September 30, 2026, the amount of accrued exit fees with respect to Term Loan A was $0.14 million, while the amount of accrued exit fees with respect to Term Loan B was $0.33 million; as of September 30, 2026, these amounts are presented within Other long-term liabilities on the condensed consolidated balance sheet.

Deferred Finance Costs and Other Reductions to Carrying Value of Debt

In connection with entering into the term loans in December 2024, the Company incurred loan origination fees, plus various legal and other fees; these fees and costs totaling $0.92 million were deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt. Also in connection with entering into the term loans in December 2024, the Company issued certain warrants to the lenders to purchase shares of the Company’s common stock. In

16

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

accordance with applicable GAAP, the Company allocated the value of the total proceeds of $10.0 million between the term loan debt and the warrants, based on the relative fair values of each; as a result, the Company recognized a $0.48 million increase to stockholders’ equity as additional paid-in capital for the allocated fair value of the warrants, and an offsetting decrease to the net carrying value of the term loan debt. From December 12, 2024, and through April 20, 2025, these reductions to the carrying value of the term loan debt totaling $1.40 million were being amortized to interest expense over the term of the debt using the effective interest method. The $1.26 million remaining unamortized balance of such amounts was written-off as part of the loss on early extinguishment of debt upon the closing of the April 21, 2025 debt refinancing.

In connection with the debt refinancing transaction on April 21, 2025, the Company incurred certain legal costs and other fees; these fees and costs totaling $0.53 million were deferred on the Company’s balance sheet as a reduction of the carrying value of the term loan debt. Also in connection with the April 21, 2025 debt refinancing transaction, the Company issued certain warrants to UTG to purchase shares of the Company’s common stock. In accordance with GAAP, the Company allocated the value of the total proceeds of $13.62 million between the term loan debt and the warrants, based on the relative fair values of each; as a result, the Company recognized a $0.58 million increase to stockholders’ equity as additional paid-in capital for the allocated fair value of the warrants, and an offsetting decrease to the net carrying value of the term loan debt. These reductions to the carrying value of the term loan debt totaling $1.11 million are being amortized to interest expense over the term of the debt using the effective interest method.

​

Senior Secured Notes

​

On April 13, 2026, the Company entered into certain agreements with Smithline Family Trust II (“SFT”), Quick Capital, LLC (“Quick”), and IPX (collectively, the “Purchasers”), pursuant to which the Company issued and sold to the Purchasers 12.5% Senior Secured Notes due April 13, 2027 in the original principal amount of $3,005,780 (the “Secured Notes”) and 100,579 shares of the Company’s common stock. The Secured Notes were issued with an original issue discount, such that the net cash proceeds received by the Company after the discount were $2.60 million. The Company’s obligations under the Secured Notes are guaranteed by certain direct and indirect subsidiaries of the Company pursuant to a subsidiary guarantee, and are secured by the assets of the Company and the subsidiary guarantors pursuant to a security agreement.

​

At any time after the occurrence of an event of default under the Secured Notes and for so long as such event of default is continuing, the Secured Notes are convertible into shares of common stock of the Company (i) initially at a fixed conversion price equal to $1.165 per share in the case of SFT and Quick or $1.435 per share in the case of IPX, and (ii) in the case of SFT and Quick, after May 17, 2026, at a price equal to the lesser of (a) 85% multiplied by the lowest volume weighted average price of the common stock during the 10-trading day period prior to conversion and (b) $1.165 in the case of SFT and Quick. In addition, to the extent that Company is listed on the Nasdaq Capital Market, the aggregate number of shares of common stock issuable to the Purchasers and any subsequent holder of the Secured Note shall not exceed 19.9% of the total number of shares of common stock outstanding or of the voting power of the common stock as of April 13, 2026 less the shares issued pursuant to the securities purchase agreement unless the Company has obtained stockholder approval in compliance with Nasdaq Listing Rule 5635(d) to authorize the issuance of shares of common stock in connection with the conversion or exchange of all Secured Notes.

​

Under the conversion feature described above, because the post-May 17, 2026 conversion price varies with the market price of the Company’s common stock, this feature is not considered indexed to the Company’s own stock under ASC 815-40 and therefore represents an embedded derivative. As the feature is exercisable only upon an event of default, and management considers the likelihood of such an occurrence to be remote, the Company concluded that the fair value of the embedded derivative was not material and has therefore not recorded a separate liability. The Company will reassess this conclusion each reporting period.

​

Fees incurred in connection with the transactions described above were approximately $0.1 million.

17

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

As part of the transactions described above, IPX (a related party) purchased $57,803 original principal amount of the Secured Notes and purchased 1,742 shares of common stock, on the same terms as the other Purchasers, except that the shares of common stock purchased by IPX were priced at current market value.  

Principal

The Company is required to make $0.10 million monthly payments on the Secured Notes commencing October 13, 2026, with the balance due at maturity. In addition, the terms of the Secured Notes require mandatory prepayments in certain specified situations, including the sale of any brand or license, or the sale of any debt or equity securities by the Company.

The Company made additional principal payments to the lenders during the current quarter and current nine months totaling $0.02 million and $0.47 million, respectively. The remaining principal balance due under the Secured Notes at September 30, 2026 was $2.53 million.

Interest

Interest is payable monthly, on the thirteenth day of each calendar month, beginning on May 13, 2026 and on the maturity date, at a rate of 12.5% per annum.

For the current quarter and current nine months, the Company incurred interest expense (including interest paid in cash, and the amortization of deferred finance costs and OID) related to the Secured Notes of approximately $0.35 million and $0.60 million, respectively.

​

Deferred Finance Costs and Other Reductions to Carrying Value of Debt

In connection with the issuance of the Secured Notes in April 2026, the Company incurred various fees and costs totaling $0.35 million, which were deferred on the Company’s balance sheet as a reduction of the carrying value of the related debt. Also in connection with the issuance of the Secured Notes in April 2026, the Company issued shares of common stock as described above. In accordance with applicable GAAP, the Company allocated the value of the total proceeds between the debt and the shares of common stock, based on the relative fair values of each; as a result, the Company recognized a $0.12 million increase to stockholders’ equity as additional paid-in capital for the allocated fair value of the shares, and an offsetting decrease to the net carrying value of the debt. These reductions to the carrying value of the Secured Notes (plus the impact of the original issue discount of $0.41 million) totaling $0.88 million are being amortized to interest expense over the term of the debt using the effective interest method.

​

7.    Stockholders’ Equity  

​

Equity Line Facility

​

On January 21, 2026, the Company entered into a common stock purchase agreement with White Lion Capital, LLC (“White Lion”), pursuant to which White Lion has committed to purchase up to $15.0 million of the Company’s common stock. Under the terms and conditions of this agreement, the Company has the right, but not the obligation, to sell to White Lion, and White Lion is obligated to purchase, up to $15.0 million of the Company’s common stock. The actual amount and timing of any sales of Common Stock will be determined by the Company at its discretion.

​

The aggregate number of shares that the Company can sell White Lion under this agreement is limited to and may not exceed 1,178,173 shares (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split, or other similar transaction), which is equal to 19.9% of the total shares of the Company’s common stock outstanding immediately prior to the execution of the agreement, unless (i) the Company obtains stockholder

18

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

approval to issue additional shares in excess of this amount, or (ii) the average price paid for all shares of Common Stock issued under the agreement equals or exceeds certain levels as specified in the agreement.

In consideration for White Lion’s execution and entry into such arrangement, the Company agreed to issue White Lion $37,500 worth of common stock, with the number of shares issued determined based on the closing price of the Company’s stock on the business day immediately preceding the day on which the related registration statement is declared effective by the SEC; accordingly, the Company issued 16,094 shares to White Lion on May 6, 2026. Additionally, pursuant to the terms of an advisory agreement between the Company and Maxim Group LLC, the Company agreed to pay Maxim Group LLC a cash fee equal to 4.0% of the gross proceeds received from any sales of securities to White Lion under this arrangement.

For the three and nine months ended September 30, 2026, the Company issued an aggregate of 34,500 and 382,500 shares, respectively, under the equity line facility arrangement and received aggregate proceeds from such issuances (net of commissions) of approximately $0.04 million and $0.72 million, respectively.

Also, during the current nine months, the Company incurred approximately $0.26 million of fees and expenses (consisting of legal and accounting fees) associated with the entrance into the equity line arrangement and related registration statement, which were recorded as a reduction to additional paid-in capital.

At-the-Market Facility

On August 18, 2026, the Company entered into an equity distribution agreement with Maxim Group LLC (“Maxim”), pursuant to which the Company may offer and sell up to $10,000,000 maximum aggregate offering price of shares of common stock, from time to time through Maxim, acting as sales agent or principal, in accordance with the terms and conditions set forth therein.

The Company pays Maxim a commission of 3.0% of the gross sales price of all shares sold pursuant to this agreement. Under this agreement, Maxim may sell the shares in sales deemed to be an “at-the-market offering” as defined in the Securities Act of 1933, including sales made directly on or through the Nasdaq Capital Market or any other existing trading market for the shares or to or through a market maker. Maxim may also sell shares in privately negotiated transactions (which shall not include block trades initiated on the Nasdaq Capital Market) with the Company’s prior written approval.

The offering pursuant to the aforementioned agreement will terminate upon the earlier of (i) the sale of all of the shares subject to the agreement and (ii) termination of the agreement as permitted therein. The Company may terminate the provisions of the agreement relating to the solicitation of offers to purchase the shares in its sole discretion at any time upon delivery of written notice to Maxim; Maxim may terminate the agreement if it is not fully satisfied, in its sole discretion, with the results of its and its representatives’ review of the Company and the Company’s business by giving written notice to the Company. The agreement may also be terminated by mutual agreement of the parties.

During the three and nine months ended September 30, 2026, the Company issued an aggregate of 11,058 shares under this facility and received aggregate proceeds from such issuances (net of commissions) of approximately $0.01 million.

Also, during the current quarter and current nine months, the Company incurred approximately $0.11 million of fees and expenses (consisting of legal and accounting fees) associated with the entrance into the at-the-market facility arrangement and related registration statement, which were recorded as a reduction to additional paid-in capital.

19

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

Equity Incentive Plans

A total of 1,150,000 shares of common stock are eligible for issuance under the Company’s 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan provides for the grant of any or all of the following types of awards: stock options (incentive or non-qualified), restricted stock, restricted stock units, performance awards, or cash awards. The 2021 Plan is administered by the Company’s Board of Directors, or, at the Board’s discretion, a committee of the Board. In addition, 10,000 stock options previously granted under the Company’s 2011 Equity Incentive Plan (the “2011 Plan”) remain outstanding and shares of common stock may be issued to satisfy options previously granted under the 2011 Plan, although no new awards may be granted under the 2011 Plan.

Stock-based Compensation

Stock-based compensation expense is recorded as a component of Other selling, general and administrative expenses in the condensed consolidated statements of operations.

Total expense recognized for all forms of stock-based compensation was approximately $0.22 million and $0.15 million for the current quarter and prior year quarter, respectively. Of the current quarter expense amount, approximately $0.10 million related to employees and approximately $0.12 million related to directors and consultants. Of the prior year quarter expense amount, approximately $0.13 million related to employees and approximately $0.02 million related to directors and consultants.  

Total expense recognized for all forms of stock-based compensation was approximately $0.54 million and $0.48 million for the current nine months and prior year nine months, respectively. Of the current nine months expense amount, approximately $0.30 million related to employees and approximately $0.24 million related to directors and consultants. Of the prior year nine months expense amount, approximately $0.40 million related to employees and approximately $0.08 million related to directors and consultants.  

Stock Options

A summary of the Company’s stock options activity for the current nine months is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

​

​

​

Average

​

​

​

​

​

​

​

Weighted

​

Remaining

​

​

​

​

​

​

​

Average

​

Contractual

​

Aggregate

​

​

Number of

​

Exercise

​

Life

​

Intrinsic

​

  ​ ​ ​

Options

  ​ ​ ​

Price

  ​ ​ ​

(in Years)

  ​ ​ ​

Value

Outstanding at December 31, 2025

 

977,695

​

$

8.69

 

3.98

​

$

—

Granted

 

14,000

​

 

2.24

 

  ​

​

 

  ​

Exercised

 

—

​

 

—

 

  ​

​

 

  ​

Expired/Forfeited

 

(373,994)

​

 

(18.13)

 

  ​

​

 

  ​

Outstanding at September 30, 2026, and expected to vest

 

617,701

​

$

2.82

 

3.87

​

$

—

Exercisable at September 30, 2026

 

183,500

​

$

6.09

 

3.88

​

$

—

​

Effective January 21, 2026, certain stock options originally issued in 2019 to executive management (including the Company’s Chief Executive Officer, Chief Financial Officer, and Executive Vice President of Business Development and Treasury) to purchase an aggregate of 350,000 shares of common stock, were cancelled through mutual agreement between the Company and the respective executives. None of these options had vested, and no compensation was paid to the executives in exchange for such cancellation.

​

20

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

On April 20, 2026, the Company granted options to purchase an aggregate of 14,000 shares of common stock to non-management directors. The exercise price of the options is $2.24 per share; 50% of the options will vest on April 1, 2027 and the remaining 50% will vest on April 1, 2028.

​

Compensation expense related to stock options for the current quarter and the prior year quarter was approximately $0.01 million and $0.01 million, respectively. Compensation expense related to stock options for the current nine months and the prior year nine months was approximately $0.04 million and $0.07 million, respectively. Total unrecognized compensation expense related to unvested stock options at September 30, 2026 was approximately $0.16 million and is expected to be recognized over a weighted average period of approximately 3.54 years.

​

A summary of the Company’s non-vested stock options activity for the current nine months is as follows:

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted

​

​

​

​

 Average 

​

​

Number of

​

Grant Date 

​

  ​ ​ ​

Options

  ​ ​ ​

Fair Value

Balance at December 31, 2025

 

780,201

​

$

0.31

Granted

 

14,000

​

 

1.46

Vested

 

(10,000)

​

​

2.76

Forfeited or Canceled

 

(350,000)

​

 

—

Balance at September 30, 2026

 

434,201

​

$

0.54

​

Of the non-vested stock options outstanding at September 30, 2026, the vesting of 340,201 options is contingent upon the Company’s common stock achieving certain target prices, the vesting of 20,000 options is contingent upon the achievement of certain revenue targets, the vesting of 60,000 options is contingent upon the Company’s common stock achieving certain target prices or the Company achieving certain financial performance targets, and the vesting of 14,000 options is subject to service-based criteria.

​

Stock Awards

A summary of the Company’s restricted stock activity for the current nine months is as follows:  

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

Number of

​

Average

​

​

Restricted

​

Grant Date

​

  ​ ​ ​

Shares

  ​ ​ ​

Fair Value

Outstanding at December 31, 2025

 

96,417

​

$

13.73

Granted

 

220,240

​

 

1.59

Vested

 

(215,240)

​

 

1.58

Expired/Forfeited

 

—

​

 

—

Outstanding at September 30, 2026

 

101,417

​

$

13.16

​

On April 20, 2026, the Company issued an aggregate of 5,000 shares of common stock to non-management directors, of which 50% vests on each of April 1, 2026 and April 1, 2027.

On April 24, 2026, the Company issued 62,112 shares of common stock to a consultant, which vested immediately.

On July 23, 2026, the Company issued 37,313 shares of common stock to a consultant, which vested immediately.

In accordance with the amended employment agreement with Mr. D’Loren, the Company is paying 40% of such executive officer’s base salary via the issuance of shares of the Company’s common stock. Mr. D’Loren is permitted to pay the

21

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

withholding tax through the exchange of a portion of the shares. Under the terms of this amended agreement, the Company issued 53,175 and 115,815 shares of common stock (net of shares exchanged for withholding taxes) to Mr. D’Loren for the current quarter and current nine months, respectively, all of which vested immediately.

Compensation expense related to stock awards was approximately $0.21 million for the current quarter and approximately $0.14 million for the prior year quarter. Compensation expense related to stock awards was approximately $0.49 million for the current nine months and approximately $0.41 million for the prior year nine months. Total unrecognized compensation expense related to unvested restricted stock grants at September 30, 2026 was approximately $0.01 million and is expected to be recognized over a weighted average period of approximately 1.25 years.

Restricted Stock Units

There were no restricted stock units outstanding as of September 30, 2026 and December 31, 2025, and no restricted stock units have been issued since the inception of the 2021 Plan.

Shares Available Under the Company’s Equity Incentive Plans

At September 30, 2026, there were 58,688 shares of common stock available for future award grants under the 2021 Plan.

Shares Reserved for Issuance

As of September 30, 2026, there were 676,389 shares of common stock reserved for issuance under the Company’s Equity Incentive Plans, including 10,000 shares reserved pursuant to unexercised stock options previously granted under the 2011 Plan, 607,701 shares reserved pursuant to unexercised stock options granted under the 2021 Plan, and 58,688 shares available for issuance under the 2021 Plan.

​

As of September 30, 2026, there were also the following shares of common stock reserved for issuance that were unrelated to the Company’s Equity Incentive Plans:

​

●100,000 shares reserved pursuant to unexercised warrants related to the Halston Master License (as described below);

​

●3,052,209 shares reserved pursuant to unexercised warrants issued through various corporate transactions in 2024 and 2025, including equity offerings and debt financing transactions; and

​

●7,712,199 shares reserved related to the conversion feature upon an event of default contained within the terms of the new Senior Secured Notes issued on April 13, 2026 (see Note 6 for additional details).

​

​

22

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

Warrants

A summary of the Company’s warrants activity for the current nine months is as follows:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

​

​

​

Average

​

​

​

​

​

​

​

Weighted

​

Remaining

​

​

​

​

​

​

 

Average

 

Contractual

​

Aggregate

​

​

Number of

​

Exercise

 

Life

​

Intrinsic

​

  ​ ​ ​

Warrants

  ​ ​ ​

Price

  ​ ​ ​

(in Years)

  ​ ​ ​

Value

Outstanding at December 31, 2025

 

3,152,209

​

$

5.70

 

4.47

​

$

—

Issued

 

—

​

 

—

 

​

​

 

  ​

Exercised

 

(380,000)

​

 

0.00

1

​

​

 

  ​

Expired/Forfeited

 

—

​

 

—

 

​

​

 

  ​

Outstanding at September 30, 2026

 

2,772,209

​

$

6.49

 

4.44

​

$

—

Exercisable at September 30, 2026

 

2,672,209

​

$

6.17

 

4.35

​

$

—

​

1 Warrants exercised during the current nine months consisted of certain pre-funded warrants that were originally issued as part of a private investment in public equity transaction in December 2025.

​

In connection with the entrance into the Halston Master License in 2023 (see Note 4), the Company issued to G-III a ten-year warrant to purchase up to 100,000 shares of the Company’s common stock at an exercise price of $15.00 per share, which vests based upon certain annual royalty targets being satisfied under the license agreement. The fair value of this warrant is being recognized as a reduction of revenue over the term of the related license agreement, with an offsetting increase to stockholders’ equity as additional paid-in capital. The amount of contra-revenue recognized related to this warrant during the current quarter and prior year quarter was approximately $0.01 million in each period, and the amount of contra-revenue recognized was during the current nine months and prior year nine months was approximately $0.03 million in each period. As of September 30, 2026, no portion of this warrant had vested.

​

8. Earnings (Loss) Per Share

Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS reflects, in periods in which they have a dilutive effect, the effect of common shares issuable upon the exercise of stock options and warrants, using the treasury stock method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive.

​

​

23

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

The following table is a reconciliation of the numerator and denominator of the basic and diluted earnings (loss) per share computations for the three and nine months ended September 30, 2026 and 2025:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Nine Months Ended

​

​

September 30, 

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Numerator:

​

​

​

​

​

​

​

​

​

​

​

​

Net loss attributable to Xcel Brands, Inc. stockholders (in thousands)

​

$

(2,348)

​

$

(7,899)

​

$

(7,313)

​

$

(14,684)

​

​

​

​

​

​

​

​

​

​

​

​

​

Denominator:

​

​

​

​

​

​

​

​

​

​

​

​

Basic weighted average number of shares outstanding

 

​

6,696,860

 

​

3,918,993

​

​

6,256,136

 

​

2,904,399

Add: Effect of warrants

 

​

—

 

​

—

​

​

—

 

​

—

Add: Effect of stock options

​

​

—

​

​

—

​

​

—

​

​

—

Diluted weighted average number of shares outstanding

 

​

6,696,860

 

​

3,918,993

​

​

6,256,136

 

​

2,904,399

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic earnings (loss) per share

​

$

(0.35)

​

$

(2.02)

​

$

(1.17)

​

$

(5.06)

Diluted earnings (loss) per share

​

$

(0.35)

​

$

(2.02)

​

$

(1.17)

​

$

(5.06)

​

As a result of the net loss for all periods presented, the Company calculated diluted EPS using basic weighted average shares outstanding for all such periods, as utilizing diluted shares would be anti-dilutive to loss per share. The computation of diluted EPS excludes the following potentially dilutive securities because their inclusion would be anti-dilutive:  

​

​

​

​

​

​

​

​

​

​

​

 

Three Months Ended

​

Nine Months Ended

​

 

September 30, 

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Stock options

​

617,701

​

523,994

​

617,701

​

523,994

Warrants

​

2,772,209

​

1,476,455

​

2,772,209

​

1,476,455

Total

​

3,389,910

 

2,000,449

​

3,389,910

 

2,000,449

​

​

​

​

​

​

9. Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately -0.6% and -0.3%, respectively, resulting in an income tax provision (benefit) of $0.01 million and $0.03 million, respectively.

​

The estimated annual effective income tax rate for the current nine months and the prior year nine months was approximately -0.6% and -0.5%, respectively, resulting in an income tax provision (benefit) of $0.04 million and $0.08 million, respectively.

​

For all periods presented, the federal statutory rate differed from the effective tax rate primarily due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

​

​

​

24

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

10. Related Party Transactions

Guarantee

Since October 2024, in connection with a required standby letter of credit associated with the Company’s real estate lease for offices located at 1333 Broadway (see Note 5), Mr. D’Loren has provided and continues to provide a personal guarantee to the financial institution providing such letter of credit, in order to satisfy a portion of the associated collateral requirements for the letter of credit.

​

Debt

​

As of December 31, 2025, IPX Capital, LLC (“IPX”), a company controlled by Robert W. D’Loren, Chairman and Chief Executive Officer of the Company, held a $0.50 million undivided, last-out, subordinated participation interest in Term Loan A (see Note 6). In April 2026, a $0.50 million portion of Term Loan A was sold and assigned by FEAC to IPX in connection with the refinancing of the Company’s term loan debt, and continues to be held by IPX as of September 30, 2026.

​

Additionally, in April 2026, IPX participated in the Company’s issuance of new 12.5% Senior Secured Notes due April 13, 2027. As part of this transaction, IPX purchased $57,803 original principal amount of the Senior Secured Notes and purchased 1,742 shares of common stock, on the same terms as the other purchasers participating in the issuance, except that the shares of common stock purchased by IPX were priced at the then current market value. See Note 6 for additional details related to this debt issuance.

​

In November 2026, IPX entered into an agreement with the Company to extend the maturity date of the Term Loan A to October 1, 2027 (see Note 12 for details).

​

11. Commitments and Contingencies

Contingent Obligation – Isaac Mizrahi Transaction

Under the terms of the May 31, 2022 transaction related to the sale of a majority interest in the Isaac Mizrahi brand (as subsequently amended in 2023 and 2024), the Company had agreed with WHP (the buyer) that, in the event that the aggregate royalties received by IM Topco were less than $13.5 million for the twelve-month period ending March 31, 2025 or less than $18.0 million for the year ending December 31, 2025, Xcel was obligated to transfer equity interests in IM Topco to WHP equal to 12.5% of the total outstanding equity interests of IM Topco, such that Xcel’s ownership interest in IM Topco would decrease from 30% to 17.5%, and WHP’s ownership interest in IM Topco would increase from 70% to 82.5%. During 2024, management concluded that it was virtually certain that the Company would be required to make such transfer of equity interests to WHP in 2025. As such, the Company recognized a contingent obligation of approximately $4.21 million as of December 31, 2024.

As of March 31, 2025, in accordance with the terms of the amended membership purchase agreement between Xcel and WHP, WHP became contractually entitled to receive from Xcel equity interests in IM Topco equal to 12.5% of the total outstanding equity interests of IM Topco. Also during the three months ended March 31, 2025, the Company adjusted the carrying value of the contingent obligation to its estimated fair value of $3.97 million as of March 31, 2025 in the condensed consolidated balance sheets, and recognized a $(0.24) million credit in the condensed consolidated statement of operations.

25

Table of Contents

XCEL BRANDS, INC. AND SUBSIDIARIES

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2026

(Unaudited)

On and effective April 15, 2025, such equity interests were transferred to WHP in full satisfaction and settlement of this contractual obligation, and the previously recorded liability was de-recognized by reducing the value of the asset for the investment in IM Topco.

Legal Matters

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

​

​

​

12.    Subsequent Events

​

Term Loan A Debt Amendment

​

On November 12, 2026, the Company and IPX entered into an amendment of the Term Loan A debt which resulted in the extension of the maturity date of such debt from September 20, 2027 to October 1, 2027. There were no other changes to the terms of the debt.

​

​

​

26

Table of Contents

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this report are forward-looking statements that involve a number of known and unknown risks, uncertainties and other factors, all of which are difficult or impossible to predict and many of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks are detailed in the Risk Factors section of our Form 10-K for the fiscal year ended December 31, 2024, as filed with the SEC on May 28, 2025. The words “believe,” “anticipate,” “expect,” “continue,” “estimate,” “appear,” “suggest,” “goal,” “potential,” “predicts,” “seek,” “will,” “confident,” “project,” “provide,” “plan,” “likely,” “future,” “ongoing,” “intend,” “may,” “should,” “would,” “could,” “guidance,” and similar expressions identify forward-looking statements.

Overview

Xcel Brands, Inc. (“Xcel,” the “Company,” “we,” “us,” or “our”) is a media and consumer products company engaged in the design, licensing, marketing, live streaming, and social commerce sales of branded apparel, footwear, accessories, home goods, pet products and other consumer products, and the development of influencer led brands and the acquisition of dynamic consumer lifestyle brands. Xcel was founded in 2011 with a vision to reimagine shopping, entertainment, and social media as social commerce.

Xcel owns the Halston and C Wonder brands, as well as the co-branded collaboration brands Tower Hill by Christie Brinkley, Trust. Respect. Love by Cesar Millan, GemmaMade by Gemma Stafford, and Off/Duty by Coco Rocha brand, and holds the television rights through a long-term license agreement with Mesa Mia by Jenny Martinez. Xcel also owns and manages the Longaberger by Shannon Doherty brand through its controlling interest in Longaberger Licensing, LLC.

Our brand portfolio also previously included the Judith Ripka brand (through April 27, 2026) and a noncontrolling ownership interest in the Isaac Mizrahi brand (through October 1, 2025).

Xcel is pioneering a modern consumer products sales strategy which includes the promotion and sale of products under its brands through interactive television, digital live-stream shopping, social commerce, brick-and-mortar retailers, and e-commerce channels to be everywhere its customers shop. The Company’s previously owned and current brands have generated more than $5 billion in retail sales via livestreaming in interactive television and digital channels alone and have over 20,000 hours of content production time in live-stream and social commerce. The Company’s brand portfolio reaches more than 46 million social media followers with broadcast reaching 200 million households.

Xcel currently operates in a working-capital light model, with our licensees and/or retail partners responsible for the procurement and sale of inventory. As such, our revenues primarily consist of royalty revenues, and we do not have risk of carrying aged inventory. As a result, fluctuations in product costs and tariffs do not have a direct impact on us, but do impact us indirectly as our royalty revenues are typically based on the net sales and success of our licensees.

Our objective is to build a diversified portfolio of lifestyle consumer products brands through organic growth and the strategic acquisition of new brands. To grow our brands, we are focused on the following primary strategies:

●licensing of our brands for sale through interactive television (e.g., QVC, HSN, etc.);
●licensing of our brands to retailers that sell to the end consumer;
●licensing our brands to manufacturers and retailers for promotion and distribution through e-commerce, social commerce, live streaming, and traditional brick-and-mortar retail channels; and
●acquiring additional consumer brands and integrating them into our operating platform, and leveraging our operating infrastructure and distribution relationships.

27

Table of Contents

We believe that Xcel offers a unique value proposition to our retail and direct-to-consumer customers and our licensees for the following reasons:

●our management team, including our officers’ and directors’ experience in, and relationships within the industry;
●our deep knowledge, expertise, and proprietary technology in live streaming and social commerce;
●our design, sales, marketing, and technology platform that enables us to design trend-right product; and
●our significant media and internet presence.

Summary of Operating Results

Three months ended September 30, 2026 (the “current quarter”) compared with the three months ended September 30, 2025 (the “prior year quarter”)

Revenues

Current quarter net revenue decreased by $0.06 million to $1.06 million from $1.12 million for the prior year quarter. This decrease was primarily driven by the loss of licensing revenue as a result of the sale of the Judith Ripka brand in April 2026, partially offset by an increase in revenue from our other brands.

Direct Operating Costs and Expenses

Our total direct operating costs and expenses declined approximately 17% to $1.80 million in the current quarter compared to $2.17 million in the prior year quarter, primarily due to cost reduction actions taken by management in 2025, which reduced the Company’s payroll and benefit costs as well as other corporate overhead expenses.  

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense decreased to $0.81 million in the current quarter from $0.90 million in the prior year quarter; this decline was primarily attributable to the sale of the Judith Ripka brand trademarks in April 2026.

For the prior year quarter, we recognized a $5.49 million loss related to our equity investment in IM Topco. However, as the remaining IM Topco equity interest was transferred to WHP on October 1, 2025, there were no earnings or losses from equity investments for the current quarter.

Interest and Finance Expense

Interest and finance expense was approximately $0.78 million for the current quarter, compared with approximately $0.52 million for the prior year quarter. This increase was primarily attributable to higher interest rates on the Company’s outstanding debt portfolio during the current quarter as compared with the prior year quarter, while the average debt balance outstanding during the quarter was relatively consistent year-over-year.

Income Taxes

The estimated annual effective income tax rate for the current quarter and the prior year quarter was approximately -0.6% and -0.3%, respectively, resulting in an income tax provision (benefit) of $0.01 million and $0.03 million, respectively. For both periods, the federal statutory rate differed from the effective tax rate primarily due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods

28

Table of Contents

​

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $2.35 million for the current quarter, compared with a net loss of $7.90 million for the prior year quarter, due to the combination of the factors outlined above.

Non-GAAP Net Income (Loss), Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $1.30 million, or $(0.19) per diluted share (“non-GAAP diluted EPS”), for the current quarter and a non-GAAP net loss of $1.34 million, or $(0.34) per diluted share, for the prior year quarter. Non-GAAP net income (loss) is a non-GAAP unaudited term, which we define as net income (loss) attributable to Xcel Brands, Inc. stockholders, exclusive of amortization of trademarks, income (loss) from equity investments, stock-based compensation and cost of licensee warrants, loss on early extinguishment of debt (if any), charges related to the sale of the Judith Ripka brand (if any), and income taxes (if any). Non-GAAP net income (loss) and non-GAAP diluted EPS measures do not include the tax effect of the aforementioned adjusting items, due to the nature of these items and the Company’s tax strategy.

We had Adjusted EBITDA of approximately $(0.46) million for the current quarter, compared with approximately $(0.65) million for the prior year quarter. Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to Xcel Brands, Inc. stockholders before interest and finance expense (including loss on extinguishment of debt, if any), accretion of lease liability for exited leases, income taxes, other state and local franchise taxes, depreciation and amortization, income (loss) from equity investments, charges related to the sale of the Judith Ripka brand (if any), stock-based compensation and cost of licensee warrants, and costs associated with restructuring of operations.

Management uses non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to the Company’s results of operations. Management believes non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus, these non-GAAP measures provide supplemental information to assist investors in evaluating the Company’s financial results.

Non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA in a different manner than we calculate these measures.

In evaluating non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this report. Our presentation of non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any other unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income (loss), non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.

​

29

Table of Contents

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:

​

​

​

​

​

​

​

​

​

 

Three Months Ended

​

​

September 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Net loss attributable to Xcel Brands, Inc. stockholders

​

$

(2,348)

​

$

(7,899)

Amortization of trademarks

​

 

801

​

 

876

Loss from equity investments

​

​

—

​

​

5,494

Stock-based compensation and cost of licensee warrants

​

 

234

​

 

161

Income tax provision (benefit)

​

​

13

​

​

25

Non-GAAP net loss

​

$

(1,300)

​

$

(1,343)

​

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Diluted loss per share

​

$

(0.35)

​

$

(2.02)

Amortization of trademarks

​

 

0.12

​

 

0.23

Loss from equity investments

​

​

—

​

​

1.40

Stock-based compensation and cost of licensee warrants

​

 

0.04

​

 

0.04

Income tax provision (benefit)

​

​

0.00

​

​

0.01

Non-GAAP diluted EPS

​

$

(0.19)

​

$

(0.34)

Non-GAAP weighted average diluted shares

​

 

6,696,860

​

 

3,918,993

​

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

​

September 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Net loss attributable to Xcel Brands, Inc. stockholders

​

$

(2,348)

​

$

(7,899)

Interest and finance expense

​

​

782

​

​

522

Accretion of lease liability for exited lease

​

​

29

​

​

48

Income tax provision (benefit)

​

​

13

​

​

25

State and local franchise taxes

​

​

18

​

​

10

Depreciation and amortization

​

​

812

​

​

896

Loss from equity investments

​

​

—

​

​

5,494

Stock-based compensation and cost of licensee warrants

​

 

234

​

 

161

Costs associated with restructuring of operations

​

​

—

​

​

90

Adjusted EBITDA

​

$

(460)

​

$

(653)

​

Nine months ended September 30, 2026 (the “current nine months”) compared with the nine months ended September 30, 2025 (the “prior year nine months”)

Revenues

Current nine months net revenue decreased by approximately $0.44 million to $3.33 million from $3.77 million for the prior year nine months. This decrease was primarily driven by the combination of (i) the loss of licensing revenues related to the Judith Ripka brand as a result of the sale of this brand in April 2026, and (ii) Qurate’s transition to a new apparel supplier for the C Wonder brand in December 2025, which negatively impacted Qurate sales for this brand and our associated licensing revenues during the first quarter of 2026.

30

Table of Contents

Direct Operating Costs and Expenses

Overall direct operating costs and expenses declined approximately 10% to $5.73 million in the current nine months compared to $6.35 million in the prior year nine months. This decrease was primarily attributable to lower payroll and benefits costs as well as lower corporate overhead costs, driven by cost reduction actions taken by management in 2025.

Other Operating Costs and Expenses (Income)

Depreciation and amortization expense decreased to $2.52 million in the current nine months from $2.70 million in the prior year nine months; this decline was primarily attributable to the sale of the Judith Ripka brand trademarks in April 2026.

During the current year nine months, we also recognized approximately $0.10 million of charges related to the sale of the Judith Ripka trademarks.

For the prior year nine months, we recognized a $6.01 million loss related to our equity investment in IM Topco. However, as the remaining IM Topco equity interest was transferred to WHP on October 1, 2025, there were no earnings or losses from equity investments for the current nine months.

Interest and Finance Expense

Interest and finance expense was approximately $2.25 million for the current nine months, compared with approximately $3.42 million for the prior year nine months. This $1.17 million decrease was primarily attributable to the $1.85 million loss on early extinguishment of debt recognized in the prior year nine months related to the April 2025 refinancing of our term loan debt, compared with a much smaller comparable loss of $0.15 million recognized in the current nine months related to the April 2026 debt refinancing. This decrease was partially offset by higher interest expense as a result of the combination of (i) higher average overall outstanding debt balances in the current year period and (ii) higher interest rates on the Company’s outstanding debt portfolio during the current year period.

Income Taxes

The estimated annual effective income tax rate for the current nine months and the prior year nine months was approximately -0.6% and -0.5%, respectively, resulting in an income tax provision (benefit) of $0.04 million and $0.08 million, respectively. For both periods, the federal statutory rate differed from the effective tax rate primarily due to the recording of a valuation allowance against the benefit that would have otherwise been recognized, as it was considered not more likely than not that the net operating losses generated during each period will be utilized in future periods.

​

Net Loss Attributable to Xcel Brands, Inc. Stockholders

We had a net loss of $7.31 million for the current nine months, compared with a net loss of $14.68 million for the prior year nine months, due to the combination of the factors outlined above.

Non-GAAP Net Income (Loss), Non-GAAP Diluted EPS, and Adjusted EBITDA

We had a non-GAAP net loss of approximately $3.98 million, or $(0.64) per diluted share (“non-GAAP diluted EPS”), for the current nine months and a non-GAAP net loss of $3.61 million, or $(1.24) per diluted share, for the prior year nine months. We had Adjusted EBITDA of approximately $(1.64) million for the current nine months, compared with approximately $(1.65) million for the prior year nine months.

​

31

Table of Contents

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP net loss:

​

​

​

​

​

​

​

​

​

 

Nine Months Ended

​

​

September 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Net loss attributable to Xcel Brands, Inc. stockholders

​

$

(7,313)

​

$

(14,684)

Amortization of trademarks

​

 

2,478

​

 

2,627

Loss from equity investments

​

​

—

​

​

6,010

Stock-based compensation and cost of licensee warrants

​

 

566

​

 

513

Loss on early extinguishment of debt

​

​

151

​

​

1,850

Charges related to the sale of the Judith Ripka brand

​

​

96

​

​

—

Income tax provision (benefit)

​

 

44

​

 

75

Non-GAAP net loss

​

$

(3,978)

​

$

(3,609)

​

The following table is a reconciliation of diluted loss per share (our most directly comparable financial measure presented in accordance with GAAP) to non-GAAP diluted EPS:

​

​

​

​

​

​

​

​

​

​

Nine Months Ended

​

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Diluted loss per share

​

$

(1.17)

​

$

(5.06)

Amortization of trademarks

​

 

0.40

​

 

0.90

Loss from equity method investments

​

​

—

​

​

2.07

Stock-based compensation and cost of licensee warrants

​

 

0.09

​

 

0.18

Loss on early extinguishment of debt

​

​

0.02

​

​

0.64

Charges related to the sale of the Judith Ripka brand

​

​

0.02

​

​

—

Income tax provision

​

​

0.00

​

​

0.03

Non-GAAP diluted EPS

​

$

(0.64)

​

$

(1.24)

Non-GAAP weighted average diluted shares

​

 

6,256,136

​

 

2,904,399

​

The following table is a reconciliation of net loss attributable to Xcel Brands, Inc. stockholders (our most directly comparable financial measure presented in accordance with GAAP) to Adjusted EBITDA:

​

​

​

​

​

​

​

​

​

​

Nine Months Ended

​

​

September 30, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Net loss attributable to Xcel Brands, Inc. stockholders

​

$

(7,313)

​

$

(14,684)

Interest and finance expense

​

 

2,247

​

 

3,419

Accretion of lease liability for exited lease

​

​

104

​

​

168

Income tax provision (benefit)

​

 

44

​

 

75

State and local franchise taxes

​

 

78

​

 

24

Depreciation and amortization

​

 

2,518

​

 

2,695

Loss from equity investments

​

​

—

​

​

6,010

Charges related to the sale of the Judith Ripka brand

​

 

96

​

 

—

Stock-based compensation and cost of licensee warrants

​

 

566

​

 

513

Costs associated with restructuring of operations

​

​

17

​

​

129

Adjusted EBITDA

​

$

(1,643)

​

$

(1,651)

​

Liquidity and Capital Resources

​

General

As of September 30, 2026 and December 31, 2025, our unrestricted cash and cash equivalents were approximately $0.13 million and $1.15 million, respectively.

32

Table of Contents

Restricted cash at September 30, 2026 consisted of $0.62 million of cash deposited as collateral for a standby letter of credit associated with a real estate lease. Restricted cash at December 31, 2025 consisted of $0.74 million of cash deposited as collateral for a standby letter of credit associated with a real estate lease and $1.00 million of cash deposited in a bank account to satisfy a liquidity covenant in the Company’s term loan debt agreement.

Our principal capital requirements have generally been to fund working capital needs and acquire new brands. Our current “licensing plus” operating model is a working capital light business model, and generally does not require material capital expenditures. As of September 30, 2026, we had no significant commitments for future capital expenditures.

Working Capital

Our working capital (which we calculate in a non-GAAP manner as current assets less current liabilities, excluding the current portions of lease obligations, deferred revenue, and any contingent obligations payable in shares or via other non-cash means) deficit was approximately $(2.37) million and $(0.80) million as of September 30, 2026 and December 31, 2025, respectively.

Our working capital deficit as of September 30, 2026 notably includes $2.12 million of liabilities for our Senior Secured Notes, which were recently issued in April 2026 and have a maturity date of in April 2027 (see below for additional details related to this refinancing transaction). Management is seeking to refinance this debt, although we cannot provide any assurance that we will be able to do so.

Going Concern

The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As of September 30, 2026 we have incurred recurring losses, a history of cash flows used in operating activities, a working capital deficit, and an accumulated deficit. While we have undertaken significant restructuring and cost reduction efforts, obtained additional funding through a combination of equity issuances and debt financing,  and continue to explore strategic financing alternatives and operational efficiencies to improve liquidity, management has determined that there is nonetheless substantial doubt about the Company’s ability to meet its financial obligations as they become due within twelve months from the date these financial statements are issued.

​

These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management intends to continue exploring strategic financing alternatives and operational efficiencies to improve liquidity. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

​

Commentary on the components of our cash flows for the current quarter as compared with the prior year quarter is set forth below.

Operating Activities

Net cash used in operating activities was approximately $2.88 million in the current nine months, compared with approximately $5.20 million in the prior year nine months.

The current nine months net cash used in operating activities was primarily attributable to the combination of the net loss of $(7.31) million plus non-cash items of approximately $4.71 million and the net change in operating assets and liabilities of approximately $(0.28) million. Non-cash items were primarily comprised of $2.52 million of depreciation and amortization expense, and $1.64 million of aggregate non-cash interest expenses. The net change in operating assets and liabilities was primarily driven by changes in deferred revenue balances of $(0.57) million and lease-related assets and liabilities of $(0.66) million, partially offset by increases in accounts receivable of $0.42 million and other current and non-current assets of $0.31 million.

The prior year nine months net cash used in operating activities was primarily attributable to the combination of the net loss of $(14.78) million plus non-cash items of approximately $11.62 million and the net change in operating assets and

33

Table of Contents

liabilities of approximately $(2.04) million. Non-cash items were primarily comprised of $6.01 million of losses and impairment charges related to our equity method investments, $1.85 million from the loss on early extinguishment of debt, $2.70 million of depreciation and amortization expense, and $0.69 million of aggregate non-cash interest expenses. The net change in operating assets and liabilities was primarily driven by approximately $(2.05) million of payments of accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities.

Investing Activities

The current nine months cash provided by investing activities of $2.00 million was attributable to net proceeds received from the sale of the Judith Ripka brand trademarks in April 2026.

Net cash used in investing activities in the prior year nine months was comprised of purchases of equipment totaling approximately $0.01 million.

Financing Activities

Net cash used in financing activities in the current nine months was predominantly related to the debt financing and refinancing transactions executed in April 2026 (as described further below), including (i) repayment of $(3.25) million of principal under our Term Loan A debt, (ii) $3.01 million of gross proceeds received from the issuance of our new Senior Secured Notes, (iii) total payments made under the Senior Secured Notes (inclusive of original issue discount) of $(0.88) million, and (iv) payment of deferred finance costs of $(0.35) million related to the issuance of the Senior Secured Notes. In addition, we received proceeds of approximately $0.36 million (net of related fees and expenses) during the current nine months from the issuance of shares of common stock under our equity line of credit facility and at-the-market facility (as described further below).  

Net cash provided by financing activities in the prior year nine months was primarily attributable to $2.05 million of proceeds received from the delayed draw portion of the Company’s December 2024 term loan agreement, $3.62 million of proceeds received from the April 2025 refinancing of our term loan debt, and $1.97 million of proceeds generated by equity offerings undertaken in August 2025. These items were partially offset by ($0.57) million of deferred finance costs paid in connection with debt refinancing, and $(0.50) million of principal payments made on the Company’s term loan debt.  

Equity Line Facility

​

On January 21, 2026, the Company entered into a common stock purchase agreement with White Lion Capital, LLC (“White Lion”), pursuant to which White Lion has committed to purchase up to $15.0 million of the Company’s common stock. Under the terms and conditions of this agreement, the Company has the right, but not the obligation, to sell to White Lion, and White Lion is obligated to purchase, up to $15.0 million of the Company’s common stock. The actual amount and timing of any sales of Common Stock will be determined by the Company at its discretion.

​

The aggregate number of shares that the Company can sell White Lion under this agreement is limited to and may not exceed 1,178,173 shares (subject to adjustment for any reorganization, recapitalization, non-cash dividend, stock split, reverse stock split, or other similar transaction), which is equal to 19.9% of the total shares of the Company’s common stock outstanding immediately prior to the execution of the agreement, unless (i) the Company obtains stockholder approval to issue additional shares in excess of this amount, or (ii) the average price paid for all shares of Common Stock issued under the agreement equals or exceeds certain levels as specified in the agreement. Through July 31, 2026, we issued 382,500 shares under the equity line.

In consideration for White Lion’s execution and entry into such arrangement, the Company agreed to issue White Lion $37,500 worth of common stock, with the number of shares issued determined based on the closing price of the Company’s stock on the business day immediately preceding the day on which the related registration statement is declared effective by the SEC; accordingly, the Company issued 16,094 shares to White Lion on May 6, 2026. Additionally, pursuant to the terms of an advisory agreement between the Company and Maxim Group LLC, the Company agreed to pay Maxim Group

34

Table of Contents

LLC a cash fee equal to 4.0% of the gross proceeds received from any sales of securities to White Lion under this arrangement.

For the nine months ended September 30, 2026, the Company issued an aggregate of 382,500 shares under the equity line facility arrangement and received aggregate proceeds from such issuances (net of commissions) of approximately $0.72 million. Also, during the current nine months, the Company incurred approximately $0.26 million of fees and expenses (consisting of legal and accounting fees) associated with the entrance into the equity line arrangement and related registration statement, which were recorded as a reduction to additional paid-in capital.

At-the-Market Facility

On August 18, 2026, the Company entered into an equity distribution agreement with Maxim Group LLC (“Maxim”), pursuant to which the Company may offer and sell up to $10.0 million maximum aggregate offering price of shares of common stock, from time to time through Maxim, acting as sales agent or principal, in accordance with the terms and conditions set forth therein.

The Company pays Maxim a commission of 3.0% of the gross sales price of all shares sold pursuant to this agreement. Under this agreement, Maxim may sell the shares in sales deemed to be an “at-the-market offering” as defined in the Securities Act of 1933, including sales made directly on or through the Nasdaq Capital Market or any other existing trading market for the shares or to or through a market maker. Maxim may also sell shares in privately negotiated transactions (which shall not include block trades initiated on the Nasdaq Capital Market) with the Company’s prior written approval.

The offering pursuant to the aforementioned agreement will terminate upon the earlier of (i) the sale of all of the shares subject to the agreement and (ii) termination of the agreement as permitted therein. The Company may terminate the provisions of the agreement relating to the solicitation of offers to purchase the shares in its sole discretion at any time upon delivery of written notice to Maxim; Maxim may terminate the agreement if it is not fully satisfied, in its sole discretion, with the results of its and its representatives’ review of the Company and the Company’s business by giving written notice to the Company. The agreement may also be terminated by mutual agreement of the parties.

During the nine months ended September 30, 2026, the Company issued an aggregate of 11,058 shares under this facility and received aggregate proceeds from such issuances (net of commissions) of approximately $0.01 million. Also, during the current nine months, the Company incurred approximately $0.11 million of fees and expenses (consisting of legal and accounting fees) associated with the entrance into the at-the-market facility arrangement and related registration statement, which were recorded as a reduction to additional paid-in capital.

Debt Transactions and Refinancings

As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, the Company is party to certain term loans that have undergone numerous amendments. These term loans were originally entered into on December 12, 2024, with FEAC Agent, LLC (“FEAC”), as administrative agent and collateral agent, FEF Distributors, LLC, as lead arranger, and Restore Capital, LLC, as agent for certain lenders. The term loans are guaranteed by certain direct and indirect subsidiaries of the Company, and are secured by all of the assets of the Company and such subsidiaries.

On February 20, 2026 and March 20, 2026, the Company entered into the fifth and sixth amendments to the loan and security agreement with the term loan debt lenders and FEAC. Pursuant to such amendments, (i) the Company prepaid $0.50 million on Term Loan A (paid from the blocked account, as defined in the loan and security agreement) in connection with the fifth amendment and irrevocably authorized FAEC, as the administrative agent, to transfer up to $0.50 million (the “Sixth Amendment Cash Collateral”) from the blocked account to an account maintained by the Administrative Agent to be held as cash collateral securing the Obligations (as defined in the loan and security agreement); (ii) the Company irrevocably authorized the administrative agent to: (a) apply all or any portion of the Sixth Amendment Cash Collateral to repay the Term Loan A, or (b) return all or any portion of the Sixth Amendment Cash Collateral to the Company, in each case at the lenders’ sole discretion; (iii) the liquid asset covenant requirement was reduced to: (a) at all times prior to the repayment in full of the First Out Obligations (as defined in the loan and security agreement), $0.50 million minus that

35

Table of Contents

amount of Sixth Amendment Cash Collateral used to repay Term Loan A, and (b) at all times after the repayment in full of the First Out Obligations, $0; and (iv) the transaction closing date was extended to March 24, 2026.

On April 13, 2026, the Company entered into the seventh amendment to the loan and security agreement with the term loan debt lenders and FEAC, which provided for, among other things: the ability of the Company to consummate the issuance of certain senior secured notes (as described below); the ability for IPX Capital, LLC (“IPX”), a related party, to convert its $0.50 million Term Loan A to common shares of the Company at the price per share equal to $1.35, subject to adjustment; modifications to certain payment terms; modifications to certain financial covenants; modifications to certain financial reporting requirements; and the amendment of the FEAC’s role to include certain limitations. In connection with the seventh amendment, FEAC’s affiliated lenders entered into agreements whereby a $0.50 million portion of Term Loan A was sold and assigned to IPX, and the entirety of Term Loan B was sold and assigned to UTG Capital, Inc. Additionally, the Company was relieved of its obligation to pay the remaining $325,000 amendment fee as specified in the fourth amendment.

​

Also on April 13, 2026, the Company entered into certain agreements with Smithline Family Trust II (“SFT”), Quick Capital, LLC (“Quick”), and IPX (collectively, the “Purchasers”), pursuant to which the Company issued and sold to the Purchasers 12.5% Senior Secured Notes due April 13, 2027 in the original principal amount of $3,005,780 (the “Secured Notes”) and 100,579 shares of the Company’s common stock. The Secured Notes were issued with an original issue discount, such that the cash proceeds received by the Company were $2,600,000. The Company is required to make $100,000 monthly payments on the Secured Notes commencing October 13, 2026, with the balance due at maturity. The Company’s obligations under the Secured Notes are guaranteed by certain direct and indirect subsidiaries of the Company pursuant to a subsidiary guarantee, and are secured by the assets of the Company and the subsidiary guarantors pursuant to a security agreement.

​

At any time after the occurrence of an event of default under the Secured Notes and for so long as such event of default is continuing, the Secured Notes are convertible into shares of common stock of the Company (i) initially at a fixed conversion price equal to $1.165 per share in the case of SFT and Quick or $1.435 per share in the case of IPX and (ii) in the case of SFT and Quick, after May 17, 2026, at a price equal to the lesser of (a) 85% multiplied by the lowest volume weighted average price of the common stock during the 10-trading day period prior to conversion and (b) $1.165 in the case of SFT and Quick. In addition, to the extent that Company is listed on the Nasdaq Capital Market, the aggregate number of shares of common stock issuable to the Purchasers and any subsequent holder of the Secured Note shall not exceed 19.9% of the total number of shares of common stock outstanding or of the voting power of the common stock as of April 13, 2026 less the shares issued pursuant to the securities purchase agreement unless the Company has obtained stockholder approval in compliance with Nasdaq Listing Rule 5635(d) to authorize the issuance of shares of common stock in connection with the conversion or exchange of all Secured Notes.

​

As part of the transactions described above, IPX purchased $57,803 original principal amount of the Secured Notes and purchased 1,742 shares of common stock, on the same terms as the other Purchasers, except that the shares of common stock purchased by IPX were priced at current market value.  

​

The net proceeds received from the April 13, 2026 issuance of the Secured Notes and shares as described above were used to repay $2.25 million of the Term Loan A debt, and an additional $0.50 million of the Term Loan A debt was paid with the Company’s restricted cash. As such, immediately following the funding and completion of the transactions described above, the Company’s debt obligations were as follows: (1) Senior Secured Notes in the principal amount of $2.6 million, with payments commencing October 13, 2026 and a maturity date of April 13, 2027, (2) Term Loan A in the principal amount of $0.50 million, payable on the maturity date of September 20, 2027, and (3) Term Loan B in the amount of $9.9 million, payable on the maturity date of December 12, 2028.

​

In November 2026, the Company and IPX (as sole holder of the Term Loan A debt) entered into an amendment of the Term Loan A debt to extend the maturity date of such debt from September 20, 2027 to October 1, 2027. There were no other changes to the terms of the debt.

​

36

Table of Contents

Other Factors

We continue to seek to expand and diversify the types of licensed products being produced under our brands. We plan to continue to diversify the distribution channels within which licensed products are sold, in an effort to reduce dependence on any particular retailer, consumer, or market sector within each of our brands. The Halston brand, C Wonder brand, and TowerHill by Christie Brinkley brand, which together currently represent a majority of our revenues, have a core business in fashion apparel and accessories, as does the Off/Duty by Coco Rocha brand which recently launched. Our other brands – including the Longaberger by Shannon Doherty brand, which focuses on home good products; GemmaMade by Gemma Stafford and Mesa Mia by Jenny Martinez, which focus on cooking and baking related products; and Trust.Respect.Love by Cesar Millan brand, which focuses on pet-related products – help to diversify our industry focus while at the same time complement our business operations and relationships.

While the 2022 sale of a majority interest in the Isaac Mizrahi brand and the 2024 divestiture of the LOGO by Lori Goldstein brand (and, to a lesser extent, the April 2026 sale of the Judith Ripka brand) resulted in significant decreases in our licensing revenues, we have taken and continue to take actions to replace those revenues with new strategic business initiatives, as we concentrate our resources on growing our brands, launching new brands, and entering into new business partnerships. We continue to seek new opportunities, including expansion through interactive television, live streaming, and additional domestic and international licensing arrangements, and acquiring and collaborating with additional brands. The successful launch of the TowerHill by Christie Brinkley brand in 2024 is an example of this. We recently launched two new cobranded collaborations in April 2026, another in September 2026, and a fourth cobranded collection in October 2026.

Additionally, during 2023 and 2024, we restructured our business by shifting from a wholesale/licensing hybrid model to a “licensing plus” business model, divesting certain brands, and undertaking various cost-cutting measures to more efficiently operate our business and reduce and better manage our exposure to operating risks. During 2025, we continued to implement additional measures to further optimize our cost structure. As a result, we have reduced our direct operating expenses to an expected run rate of less than $10 million per annum, which represents approximately $21 million of cost savings on an annualized basis compared to our cost structure in 2022.

Nonetheless, we continue to face a number of headwinds in the current macroeconomic environment. Poor economic and market conditions, including the cumulative impacts of inflation and rising consumer debt levels, along with the impact of tariffs on goods imported into the U.S., may negatively impact consumer sentiment, decreasing the demand for apparel, footwear, accessories, home goods, and other consumer products, which would adversely affect our operating income and results of operations. If we are unable to take effective measures in a timely manner to mitigate the impact of these conditions and/or a potential recession, our business, financial condition, and results of operations could be adversely affected.

Our long-term success, however, will still remain largely dependent on our ability to build and maintain our brands’ awareness and attract customers, and contract with and retain key licensees and business partners, as well as our and our licensees’ ability to accurately predict upcoming fashion and design trends within their respective customer bases and fulfill the product requirements of the particular retail channels within the global marketplace. Unanticipated changes in consumer fashion preferences and purchasing patterns, slowdowns in the U.S. economy, and other factors noted in Item 1A of our most recent Annual Report on Form 10-K could adversely affect our licensees’ ability to meet and/or exceed their contractual commitments to us and thereby adversely affect our future operating results.  

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on our financial condition, results of operations, or liquidity.

​

37

Table of Contents

Critical Accounting Policies and Estimates

The preparation of our unaudited condensed consolidated financial statements in conformity with GAAP requires management to exercise judgment. We exercise considerable judgment with respect to establishing sound accounting policies and in making estimates and assumptions that affect the reported amounts of our assets and liabilities, our recognition of revenues and expenses, and disclosure of commitments and contingencies at the date of the financial statements. We evaluate our estimates and judgments on an on-going basis. We base our estimates and judgments on a variety of factors, including our historical experience, knowledge of our business and industry, and current and expected economic conditions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We periodically re-evaluate our estimates and assumptions with respect to these judgments and modify our approach when circumstances indicate that modifications are necessary. While we believe that the factors we evaluate provide us with a meaningful basis for establishing and applying sound accounting policies, we cannot guarantee that the results will always be accurate. Because the determination of these estimates requires the exercise of judgment, actual results could differ from such estimates.

Please refer to our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on April 15, 2026, for a discussion of our critical accounting policies and estimates. During the three months ended September 30, 2026, there were no material changes to our critical accounting policies or estimates.

​

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable to smaller reporting companies.

​

ITEM 4.    CONTROLS AND PROCEDURES

A. EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES:

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of September 30, 2026, the end of the period covered by this report.

Based on, and as of the date of such evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2026 such that the information required to be disclosed in our SEC reports is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.

B. CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING:

There have not been any changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

38

Table of Contents

PART II. OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS

From time to time, the Company becomes involved in legal claims and litigation in the ordinary course of business. The Company routinely assesses all its litigation and threatened litigation as to the probability of ultimately incurring a liability, and records its best estimate of the ultimate loss in situations where it assesses the likelihood of loss as probable. In the opinion of management, based on consultations with legal counsel, the disposition of litigation currently pending against the Company is unlikely to have, individually or in the aggregate, a materially adverse effect on the Company’s business, financial position, results of operations, or cash flows.

​

ITEM 1A.    RISK FACTORS

​

We operate in a highly competitive industry that involves numerous known and unknown risks and uncertainties that could impact our operations. The risks described below and in Part I, Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2025 are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our financial condition and/or operating results.

​

We have experienced continued declines in revenue over the past few years as a result of the sale and divesture of our largest revenue-producing brands, and our current level of revenue does not support our operations.

The 2022 sale of a majority interest in the Isaac Mizrahi brand and the 2024 divestiture of the LOGO by Lori Goldstein brand (and, to a lesser extent, the April 2026 sale of the Judith Ripka brand) resulted in significant decreases in our licensing revenue. As a result of our declining revenue and despite various cost-cutting measures to more efficiently operate our business and reduce and better manage our exposure to operating risks, and additional measures to further optimize our cost structure, our current revenue level does not support our operations, as our current revenue level is below our current level of direct operating expenses. If we are unable to significantly increase our revenue, we will continue to incur significant losses and may not be able to continue operations.

Our failure to meet the continued listing requirements of the Nasdaq Stock market could result in a delisting of our common stock, which could negatively impact the market price and liquidity of our common stock and our ability to access the capital market.

On September 29, 2026, we received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying us that the minimum bid price per share for our common stock fell below $1.00 for a period of 30 consecutive business days. Therefore, we did not meet the minimum bid price requirement set forth in the Nasdaq Listing Rules.

The letter also states that pursuant to Nasdaq Listing Rules 5810(c)(3)(A), we will be provided 180 calendar days to regain compliance with the minimum bid price requirement, or until March 29, 2027.

In accordance with Nasdaq Listing Rule 5810(c)(3)(A), we can regain compliance if, at any time during such 180-day period, the closing bid price of our common stock is at least $1.00 for a minimum period of 10 consecutive business days.  If by March 29, 2027, we do not regain compliance with the Nasdaq Listing Rules, we may be eligible for additional time to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii). We would also need to provide written notice to Nasdaq of our intention to cure the minimum bid price deficiency during the second compliance period by effecting a reverse stock split, if necessary. As part of its review process, the Nasdaq staff will make a determination of whether it believes we will be able to cure this deficiency. Should the Nasdaq staff conclude that we will not be able to cure the

39

Table of Contents

deficiency, or should we determine not to submit a transfer application or make the required representation, Nasdaq will provide notice that our shares of common stock will be subject to delisting.

If we do not regain compliance within the allotted compliance period, including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that our shares of common stock will be subject to delisting from the Nasdaq Capital Market. At such time, we may appeal the delisting determination to a hearings panel.

If our shares of common stock were to lose their status on Nasdaq, we believe that they would likely be eligible to be quoted on the inter-dealer electronic quotation and trading system operated by OTC Markets Group Inc., commonly referred to as the Pink Open Market, and we may also qualify to be traded on the OTCQB market (The Venture Market). These markets are generally not considered to be as efficient as, and not as broad as, Nasdaq. Selling our shares on these markets could be more difficult because smaller quantities of shares would likely be bought and sold, and transactions could be delayed. In addition, in the event our shares are delisted, broker-dealers have certain regulatory burdens imposed upon them, which may discourage broker-dealers from effecting transactions in our common stock or even holding our common stock, further limiting the liquidity of our common stock. These factors could result in lower prices and larger spreads in the bid and ask prices for our common stock.

We intend to monitor our closing bid price and the market value of our publicly held common stock between now and March 29, 2027, and will consider available options to resolve our noncompliance with the minimum bid price requirement, as may be necessary. There can be no assurance that we will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with other Nasdaq listing criteria.

ITEM 2.   

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following table provides information with respect to stock purchased and retired by the Company during the three months ended September 30, 2026.

​

​

​

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

​

  ​ ​ ​

Total Number of Shares

  ​ ​ ​

Maximum Number (or

​

​

​

​

​

​

​

of Common Stock

​

Approximate Dollar

​

​

Total Number of

​

​

​

​

Purchased as

​

Value) of Common

​

​

Shares of

​

Average

​

Part of a Publicly

​

Stock That May Yet

​

​

Common Stock

​

Price per

​

Announced

​

Be Purchased Under

Period

​

Purchased

​

Share

​

Plan or Program

​

the Plan or Program

July 1, 2026 to July 31, 2026 (i)

 

11,402

​

$

1.20

 

—

 

—

August 1, 2026 to August 31, 2026 (i)

​

14,713

​

​

0.93

​

—

​

—

September 1, 2026 to September 30, 2026 (i)

​

19,547

​

​

0.70

​

—

​

—

Total

 

45,662

​

$

0.90

 

—

 

—

​

​

(i) The shares were exchanged from executives in connection with the income tax withholding obligations on behalf of such executives from the receipt of stock awards. The 2011 Plan and 2021 Plan allow for award holders to surrender vested shares to cover withholding tax liabilities.  

​

ITEM 3.    DEFAULTS UPON SENIOR SECURITIES

None.

​

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

​

40

Table of Contents

ITEM 5.    OTHER INFORMATION

On November 12, 2026, the Company and IPX entered into an amendment of the Term Loan A debt which resulted in the extension of the maturity date of such debt from September 20, 2027 to October 1, 2027. There were no other changes to the terms of the debt.

​

ITEM 6.    EXHIBITS

The following exhibits are filed herewith:

​

​

​

10.1 Eighth Amendment to Loan and Security Agreement, dated as of November 12, 2026

31.1 Rule 13a-14(a)/15d-14(a) Certification (CEO)

31.2 Rule 13a-14(a)/15d-14(a) Certification (CFO)

32.1 Section 1350 Certification (CEO) *

32.2 Section 1350 Certification (CFO) *

101.INS Inline XBRL Instance Document

101.SCH Inline XBRL Taxonomy Extension Schema Document

101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF Inline XBRL Taxonomy Extension Definitions Linkbase Document

101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document

104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

​

* Furnished herewith.

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 16, 2026

By:

/s/ Robert W. D’Loren

 

 

Name: Robert W. D’Loren

 

 

Title: Chairman and Chief Executive Officer

 

 

 

 

By:

/s/ James F. Haran

 

 

Name: James F. Haran

 

 

Title: Chief Financial Officer and Vice President

​

41

Keep reading